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SUMMARY 
C-type lectin receptors (CLRs) are versatile platforms that sense a diversity of endogenous and 
exogenous ligands that may trigger differential responses. A prototypical example of this 
adaptability is the myeloid CLR Mincle. Classically viewed as an activating receptor, Mincle 
responds to several “non-self” ligands derived from pathogens contributing in most cases to the 
generation of immunity against the infection. However, Mincle-sensing of “non-self” ligands 
can also lead to immunosuppression directly favouring an anti-inflammatory response, or 
indirectly inhibiting heterologous receptors signalling. Here, we have found that human and 
mouse Mincle bind to a ligand released by Leishmania, a eukaryote parasite that effectively 
evades the immune system. Mincle-deficient mice had less pathology and lower parasite burden 
compared to wild-type mice after Leishmania major infection. Mincle deficiency enhanced 
adaptive immunity against the parasite, correlating with increased activation and migration of 
Mincle-deficient dendritic cells (DCs). Leishmania triggered a Mincle-dependent inhibitory axis 
characterized by SHP1 coupling to the FcRγ chain. In conclusion, Leishmania shifts Mincle to 
an inhibitory ITAM configuration that favours pathogen-mediated immune scape impairing DC 
activation. 
On the other hand, we have found that Mincle detects mucosa-associated commensals. 
Interaction of commensals with Mincle triggered DC activation through the classical ITAM 
configuration characterized by Syk coupling to the FcRγ chain. Mincle sensing of commensals 
in Peyer´s patches induced IL-6 and IL-23p19 expression and regulated intestinal Th17 cells 
and IL-17-secreting innate lymphoid cells (ILCs). These cells produce IL-17 and IL-22 that are 
critical for maintenance of the intestinal barrier function. Consequently, Mincle-deficient or 
CD11c-Cre Sykflox/flox mice showed impaired production of intestinal antimicrobial peptides and 
IgA, resulting in increased systemic translocation of gut microbiota and liver inflammation.  
Thus, sensing of commensals by Mincle reinforces intestinal immune barrier and promotes host-
microbiota mutualism, preventing systemic inflammation. Our work supports the notion that 
Mincle can couple to an activating or to an inhibitory ITAM configuration depending on the 
nature of the ligand.   
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RESUMEN 
Los receptores de lectina tipo C (CLRs, del inglés C-type lectin receptors) son estructuras 
versátiles que reconocen una gran variedad de ligandos endógenos y exógenos que van a 
generar diferentes respuestas. Un ejemplo destacable de esta adaptabilidad, es el CLR mieloide, 
Mincle. Tradicionalmente considerado un receptor activador, Mincle responde a varios ligandos 
“no propios” derivados de patógenos, contribuyendo en la mayoría de los casos a la generación 
de inmunidad frente a la infección. Sin embargo, el reconocimiento de ligandos “no propios” 
por parte de Mincle puede también generar inmunosupresión de manera directa induciendo una 
respuesta anti-inflamatoria o indirectamente, inhibiendo la señalización de receptores 
heterólogos. En este trabajo, hemos encontrado que Mincle humano y de ratón, reconoce un 
ligando excretado por Leishmania, un parasito eucariota capaz de evadir eficientemente la 
respuesta inmunológica. Los ratones deficientes para Mincle tenían menos patología y carga 
parasitaria comparados con animales de genotipo silvestre tras la infección con Leishmania 
major. La deficiencia de Mincle aumentaba la respuesta adaptativa frente al parasito, lo que 
correlacionaba con una mayor activación y migración de las células dendríticas (DCs, del inglés 
dendritic cells) deficientes para Mincle. Leishmania inducía a través de Mincle una cascada de 
señalización inhibidora caracterizada por la unión de SHP1 a la cadena de FcRγ. En conclusión, 
Leishmania cambia Mincle hacia una configuración inhibidora del ITAM que favorece la 
evasión de la respuesta inmunológica por parte del parásito, impidiendo la activación de las 
DCs.  
Por otro lado, hemos encontrado que Mincle reconoce los comensales asociados a la mucosa 
intestinal. La interacción de Mincle con los comensales conducía a la activación de las DCs, a 
través de la configuración clásica del ITAM, caracterizada por la unión de Syk a la cadena 
FcRγ. El reconocimiento de los comensales vía Mincle en las placas de Peyer inducía la 
expresión de IL-6 e IL-23p19 y regulaba las células Th17 y las ILCs (del inglés innate lymphoid 
cells) productoras de IL-17 en el intestino. Estas células producen IL-17 e IL-22, ambas críticas 
para el mantenimiento de la barrera intestinal. En consecuencia, los ratones deficientes para 
Mincle o CD11c-Cre Sykflox/flox mostraron menor producción de péptidos antimicrobianos e IgA, 
lo que conllevaba una mayor extravasación de los comensales e inflamación hepática. Por lo 
que, la detección de los comensales vía Mincle refuerza la barrera intestinal a nivel 
inmunológico, y promueve el mutualismo hospedador-microbiota, evitando la inflamación 
sistémica. Nuestros hallazgos respaldan la noción de que Mincle puede acoplarse a un ITAM 
con configuración activadora o inhibidora dependiendo de la naturaleza del ligando. 
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PKB: Protein kinase B 
PPs: Peyer’s patches  
PRRs: Pattern recognition receptors 
RegIIIγ: Regenerating islet-derived protein 3 gamma 
RIG: Retinoic acid-inducible gene 
RORγt: Retinoic acid receptor (RAR)-related orphan receptor gamma t 
ROS: Reactive oxygen species  
rRNA: Ribosomal RNA 
RT: Room temperature 
SAMPs:  Self-associated molecular patterns 
SAP-130: Sin3-associated protein 130 
SED: Subepithelial dome 
SFB: Segmented filamentous bacteria 
SHP-1/-2:  Src homology region 2 domain-containing phosphatase -1/-2 
SIGNR3: Specific intracellular adhesion molecule-3 grabbing non-integrin homolog-related 3 
SLA: Soluble Leishmania antigen 
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SLPs: Surface layer proteins 
SN: Supernatant 
SPF: Specific pathogen free 
Syk: Spleen tyrosine kinase  
TDB: Trehalose-6,6-dibehenate 
TDM: Trehalose-6,6-dimycolate  
Tfh: T follicular helper cells 
Th: CD4+ T helper cells 
TNFα:  Tumour necrosis factor-α  
Treg: CD4+ regulatory T cells 
Tx-100: Triton X 100 
β-GlcCer: β-glucosylceramide  
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1. INTRODUCTION 
1.1 The immune system at the barriers 
The immune system has evolved to react to complex environmental clues. These signals are 
continuously present at barrier tissues, such as skin and the gastrointestinal tract. These barrier 
tissues have site-specific beneficial microorganisms referred to as the microbiota, while at the 
same time, are the entry for most of the challenges, including pathogenic microorganisms (Fig. 
1.1). In these conditions, the immune system has to work to eliminate pathogenic microbes and 
foreign substances, avoiding damage of self-tissues and facilitating the symbiosis to resident 
microbiota (Belkaid and Artis, 2013). The immune system has cellular and humoral 
components. These components belong to the innate or adaptive arms of the immune system. 
The innate arm is the first line of contact with the surrounding world. Lymphoid and myeloid 
cells composed the innate immune system, including innate lymphoid cells (ILCs), natural killer 
cells (NK), neutrophils, eosinophils, basophils, mast cells, macrophages and dendritic cells 
(DCs) (Gasteiger et al., 2017, Riera Romo et al., 2016). Myeloid cells, mainly macrophages and 
DCs, are key cells modulating the generation of the adaptive response, mainly B and T cell 
responses (Fig. 1.1). There are at least three types of mature T cells: CD4+ helper (Th) or 
regulatory T cells (Treg) and CD8+ cytotoxic T cells (Tc). Additional layers of complexity come 
from the existence of several subtype of CD4+ Th cells ( Th1, Th2 and Th17) and Treg ( natural 
or inducible), which can differ from each other in their origin, pattern of cytokine production 
and functions (Nicholson, 2016). 
 
1.2 Myeloid-cells Pattern Recognition Receptors (PRRs) 
To influence the adaptive immune response, myeloid cells are equipped with a variety of germ 
line-encoded receptors, called pattern recognition receptors (PRRs) (Fig. 1.1). Charles Janeway 
hypothesised the existence of these receptors as sensors of pathogen-associated molecular 
patterns (PAMPs) on pathogens as inducers of immunity (Janeway, 1989). However, PAMPs 
are not exclusive to pathogens, and are present in the resident microbiota (Chu and Mazmanian, 
2013). In addition, these receptors can also recognize endogenous damage-associated molecular 
patterns (DAMPs), host cellular components released upon cell death (Jounai et al., 2012). 
DAMPs/PAMPs recognition by PRRs, leads to innate cell activation, including degranulation 
and phagocytosis, but also affecting antigen presentation and co-stimulation, which in turn 
shapes the nature of the adaptive response (Iwasaki and Medzhitov, 2010).  
PRRs families comprise transmembrane and intracellular receptors. The former include Toll-
like receptors (TLRs) and C-type lectin receptors (CLRs), which are found at the cell surface or 
in endocytic compartments, where they recognize microbial signatures and modulate antigen 
presentation as well as cytokine/chemokine production. The latter contains nucleotide-binding 
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oligomerization domains (NOD)-like receptors (NLRs), retinoic acid-inducible gene (RIG-I)-
like receptors (RLRs) and DNA sensors which are located in the cytoplasm, where they detect 
the presence of intracellular pathogens and induce IL-1β or type I IFN production, respectively 
(Brubaker et al., 2015) (Fig. 1.1).  
 
Figure 1.1 Components of the innate and adaptive immune system at the barrier tissues. 
Top: the physical barriers, including the skin, and the intestine, together with their resident 
microbiota are shown. Left: representation of the innate immune myeloid cells (macrophages 
and dendritic cells) equipped with several pattern recognition receptors (PRRs). Right: the 
adaptive cellular components (CD4+, CD8+ T cells and B cells) are shown. NOD, nucleotide-
binding oligomerization domains; RIG-I, retinoic acid-inducible gene; IECs, intestinal epithelial 
cells.  
 
1.3 Myeloid C-type lectin Receptors (CLRs) 
1.3.1 Families of myeloid CLRs 
C-type lectin receptors (CLRs) are a superfamily of proteins that possess one or more C-type 
lectin-like domain (CTLD). The CTLD is a conserved structural motif arranged as two protein 
loops stabilized with intra-chain disulphide bridges. The second loop is more flexible than the 
first and generally contains the ligand-binding site. CTLD often mediates glycoconjugates 
binding, in a Ca2+-dependent manner through conserved residues present in a module termed 
carbohydrate recognition domain (CRD). This includes the EPN (Glutamic acid–Proline–
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Asparagine) or the QPD (Glutamine–Proline–Aspartic acid) motifs, which determine specificity 
for mannose-based or galactose-based ligands, respectively. However, CTLD may also 
recognize proteins, lipids or even inorganic ligands. CLRs superfamily can be classified into 17 
groups (I-XVII) based on their phylogeny and their structural domain organization. Myeloid 
CLRs, express by macrophages and DCs, mainly belong to group II, V and VI. Group II and V 
are type II transmembrane proteins with a short cytoplasmic tail, a transmembrane domain, and 
an extracellular single CTLD, which in the group II possesses a Ca2+-dependent CRD motif, but 
in the group V lacks the Ca2+ or carbohydrates binding sites. Group VI are type I 
transmembrane receptors with an extracellular domain encompassing an N-terminal ricin-like 
domain, a fibronectin type 2 domain and 8 or 10 CTLDs. The extracellular domain is linked to a 
transmembrane region and a short cytoplasmic domain (Brown et al., 2018) (Fig. 1.2).  
Apart of this classification based on structural differences present in their extracellular domain, 
myeloid CLRs can be grouped into four categories, depending on the presence of different 
intracellular signalling motifs (Sancho and Reis e Sousa, 2012) (Fig. 1.2) : 
1. Immunoreceptor tyrosine-based activating motif (ITAM)-coupled CLRs, which have 
YxxL tandem repeats (being “Y” tyrosine , “x” any aminoacid and “L” leucine) in their 
intracellular tail or can interact with ITAM-containing adaptor proteins, as Fc receptor γ 
(FcRγ) chain or DNAX-activation protein 12 (DAP12). Mincle (CLEC4E) and Dectin-2 
(CLEC6A in human, Clec4n in the mouse) are representative examples of this group; 
both receptors use the FcRγ chain adaptor for their signalling.  
2. Hemi-ITAM (hemITAM)-bearing CLRs, which contain a single tyrosine within an 
YxxL motif in their cytoplasmic domain, Dectin-1 (CLEC7A) and DNGR-1 (CLEC9A) 
are prototypical examples of this category. 
3. Immunoreceptor tyrosine-based inhibitory motif (ITIM)-bearing CLRs, some examples 
are human DCIR (CLEC4A) and MAgH (CLEC12B).  
4. CLRs lacking these typical signalling motifs, DC-SIGN (CD209) and MMR (MRC1) 
are part of this group.  
ITAM- or hemITAM-coupled CLRs are considered activating receptors that couple to the 
spleen tyrosine kinase (Syk). Phosphorylation of the tyrosine(s) in the ITAM or hemITAM 
motifs generates docking sites for the Src-homology 2 domain (SH2) domains of Syk, which 
undergoes a conformational change permitting auto-phosphorylation and activation. Syk 
activation usually leads to the assembly of a ternary protein complex consisting of the caspase 
recruitment domain-containing protein 9 (CARD9), B cell lymphoma/leukaemia 10 (Bcl10), 
and the mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT-1). The 
formation of Card9/Bcl10/Malt1 results primarily in the induction of nuclear factor-κB (NF-
κB)-dependent responses, which leads to myeloid cells cytokine production and T cell priming. 
In addition, there are other pathways that can also be activated downstream of  particular CLRs, 
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as mitogen activated protein kinases (MAPK) (Slack et al., 2007), nuclear factor of activated T-
cells (NFAT) through phospholipase C-γ2 (Goodridge et al., 2007, Xu et al., 2009) and a Syk-
independent non-canonical NF-κB activation relying on the activation of the V-raf-1 murine 
leukemia viral oncogene homolog 1 (Raf-1) kinase (Gringhuis et al., 2009). In contrast, ITIM-
coupled CLRs do not have any activity per se but through the recruitment of tyrosine 
phosphatases, such as Src homology region 2 domain-containing phosphatase (SHP)-1 or -2, 
can mediate negative regulation of kinase-associated receptors, for example the Syk-coupled 
CLRs (Fig. 1.2). For this reason, these CLRs are ideal targets for pathogen immune escape. 
Finally, CLRs without a clear signalling motif cannot induce myeloid cell activation by 
themselves, but some of them are involved in endocytosis, thus contributing to antigen 
processing and presentation to T cells and can modulate the signalling of heterologous receptors 
(Del Fresno et al., 2018). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Families of myeloid C-type lectin Receptors (CLRs). Schematic representation of 
four CLRs categories based on their cytoplasmic signalling motifs. The name and the group 
number, based on structural features of the extracellular domain, of some prototypical examples 
of each category are shown. From the left to the right: Immunoreceptor tyrosine-based 
activating motif (ITAM)-coupled CLRs, signal via Syk through association with ITAM-
containing adaptor proteins as FcRγ chain or DAP-12, hemi-ITAM-(hemITAM)-bearing CLRs, 
signal via Syk through a single tyrosine-based motif in their cytoplasmic tail, immunoreceptor 
tyrosine-based inhibitory motif (ITIM)-containing CLRs, possess an ITIM motif that can recruit 
phosphatases SHP-1 and SHP-2 and ITAM-ITIM-independent CLRs, do not signal through Syk 
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or phosphatases. Mincle, macrophage-inducible C-type lectin; Dectin-2/1; dendritic-cell-
associated C-type lectin-2/1;DNGR-1, DC, NK lectin group receptor-1; DCIR, dendritic cell 
immunoreceptor; MAgH, macrophage antigen H; DC-SIGN; dendritic cell-specific ICAM-
grabbing non-integrin; MMR, macrophage mannose receptor; Syk, spleen tyrosine kinase; 
CTLD, C-type lectin-like domain; (SHP)-1 or -2, src homology region 2 domain-containing 
phosphatase; NF-κB, nuclear factor-κB  
 
1.3.2 Ligands characteristics influence myeloid CLRs signalling  
Apart of the mentioned intracellular motif borne by myeloid CLRs, the nature and the state of 
the ligand influence CLRs signalling. Monomeric or oligomeric state of the ligand can affect 
how the ligand interact with the CLR.  Soluble ligands for CLRs are poor activators, whereas 
the same ligands in plated form or particulate ligands, promote an efficient activating signalling 
(Iborra and Sancho, 2015). As described for other PRRs, CLRs are frequently promiscuous 
receptors that can bind more than one ligand, each with a distinct affinity or avidity for the 
receptor. Ligand affinity and avidity can affect the quantity and duration of signals through the 
ITAM domain, resulting in differential responses (Hamerman et al., 2009, Yamasaki et al., 
2004). In this sense, the prototypical example of the differential effect of low affinity and 
avidity is the ITAM-containing adaptor protein FcRγ chain. Upon binding of a high-avidity 
ligand, FcRγ chain becomes fully phosphorylated and associates with the kinase Syk triggering 
an activating signal that contributes to immunity (Fig. 1.3A). However, as described for the 
FcαRI receptor, which associates with the FcRγ chain for signalling, upon interaction with low 
affinity or avidity ligands, FcRγ chain is partially phosphorylated and recruits SH2-containing 
phosphatases, a configuration termed inhibitory ITAM, being able to inhibit signals through 
heterologous receptors (Pasquier et al., 2005, Kanamaru et al., 2008, Blank et al., 2009) (Fig. 
1.3B). Accordingly, the aforementioned ITAM-associated CLRs that couple to the FcRγ chain, 
namely Mincle and Dectin-2, would thus behave similarly to ITIM-coupled CLRs. They could 
respond to low-valency ligation by soluble extracellular ligands, in a similar manner to the 
FcαRI receptor, recruiting phosphatases and inhibiting heterologous activator receptors, 
dampening immunity (Iborra and Sancho, 2015) (Fig. 1.3B).  
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Figure 1.3 Model of how nature of the ligand could influence myeloid CLRs signalling.  
(A) Upon binding of a particulate, high-avidity/affinity ligand, the FcRγ chain ITAM is fully 
phosphorylated and associates with Syk kinase, which triggers an activating signal promoting 
the development of immunity. (B) Soluble low-avidity/affinity ligands could induce hypo-
phosphorylation of the ITAM domain in the FcRγ chain associated with the CLR, termed 
“inhibitory ITAM”, which preferentially binds tyrosine phosphatases, SHP-1 or -2 (mechanism 
described for FcαRI receptor detailed above). Syk, spleen tyrosine kinase; (SHP)-1 or -2, src 
homology region 2 domain-containing phosphatase; ITAM, immunoreceptor tyrosine-based 
activating motif. They symbol P indicates a phosphorylated motif. 
 
1.4 Sensing of self and non-self by myeloid CLRs 
Myeloid CLRs usually are promiscuous and versatile receptors, some can detect endogenous 
(self) ligands, other recognize exogenous microbiota- or pathogen-derived (non-self) ligands 
and many of them can act as dual receptors sensing non-self and self-ligands. Self-ligands can 
be classified as “non-dangerous self” also known as “self-associated molecular patterns” 
(SAMPs), “dangerous-self” or DAMPs released or exposed upon cell death, and “altered-self”,  
which are neoglycans derived from transformed cells (Varki, 2011, Matzinger, 1994, Matzinger, 
2002, Eggleton et al., 2008). On the other hand, non-self ligands can be present in pathogen 
microorganisms (PAMPs) but also in the commensal microorganisms that form the microbiota, 
which we can called microbe-associated molecular patterns (MAMPs) (Chu and Mazmanian, 
2013). 
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Myeloid CLRs recognition of different kinds of self-ligands might contribute to immunity or to 
homeostasis. On the other hand, non-self ligand detection by myeloid CLRs either could drive 
immunity and inflammation to fight pathogens, or could be used by pathogens for immune 
evasion, or even could promote tolerance to commensals microorganisms at barrier tissues such 
as the skin or the intestine. 
 
1.4.1 Sensing self to trigger immunity 
Myeloid CLRs respond to “dangerous-self” ligands released or exposed upon cell death in the 
presence or not of infection.  One example is the hemITAM-bearing CLR DNGR-1 (CLEC9A). 
DNGR-1 recognizing actin filaments (F-actin) (Ahrens et al., 2012, Zhang et al., 2012, Hanc et 
al., 2015, Schulz et al., 2018) senses tissue damage concomitant with viral infections facilitating 
antigens cross-presentation to CD8+ T cells (Zelenay et al., 2012, Iborra et al., 2012 , Iborra et 
al., 2016). Then, damaged infected cells expose the actin filaments and DNGR-1 favours host 
responses after detecting this danger signal on infected cells (Fig. 1.4A). 
 
1.4.2 Sensing self to promote homeostasis 
Self-ligand recognition by myeloid CLRs can also promote homeostasis, preventing 
immunopathology. An example of this CLRs is the ITIM-bearing CLR DCIR (CLEC4A in 
human, Clec4a2 in mouse), which recognizes self-glycoproteins and maintain immune system 
homeostasis, as consequence its deletion causes autoimmune diseases in aged mice (Fujikado et 
al., 2008, Bloem et al., 2013, Maruhashi et al., 2015) (Fig. 1.4B). 
 
1.4.3 Sensing non-self to drive immunity 
Pathogens derived ligands interaction with myeloid CLRs can drive the activation of the 
immune system to fight against pathogens. The archetypal example of this situation is Dectin-1 
(CLEC7A), which recognizes β-glucans present in the cell wall of many fungi (Brown, 2006). 
Myeloid Dectin-1 engagement leads to Syk mediated -NF-κB, -MAPK and –NFAT signalling 
activation, affecting phagocytosis, respiratory burst, and the production of various inflammatory 
mediators, including the pro-inflammatory cytokines IL-6 and IL-23, contributing to antifungal 
adaptive immunity (Tang et al., 2018) (Fig. 1.4C). 
 
1.4.4 Sensing non-self to promote tolerance to commensal microorganisms 
Sensing non-self MAMPs by myeloid-CLRs is important to promote tolerance to commensal 
microorganisms at the barrier tissues such as the intestine or the skin. Remarkably, in this 
context, myeloid CLRs have to deal with both pathogens and commensals microorganisms 
(Swiatczak and Cohen, 2015). The hemITAM-bearing CLR, SIGNR3 (mouse Cd209d) 
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recognizes fungi present in the intestinal commensal microbiota, SIGNR3 deficient mice have 
more severe colitis compared to control mice, indicating that fungi recognition by SIGNR3 
promotes tolerance to the microbiota (Eriksson et al., 2013). In addition, the recognition of 
surface layer proteins (Slps) from Lactobacillus acidophilus by SIGNR3 contributes to mucosal 
barrier function (Lightfoot et al., 2015) (Fig. 1.4D). Conversely, its human homolog DC-SIGN 
(CD209) can recognize Lactobacillus reuteri and casei, modulating DC activation to drive the 
development of Treg cells that promote the tolerance to commensals microorganisms (Smits et 
al., 2005). 
1.4.5 Sensing non-self to support immune evasion  
Myeloid CLR-recognition of pathogens is key to trigger an effective immune response, but the 
fact that self-ligands recognition by myeloid CLRs can promote homeostasis, opens up the 
possibility that pathogens have evolved to mimic self-ligands to escape host immunity 
(Martinez-Lopez et al., 2018). A good example of this immune escape mechanism is the mouse 
homolog of the CLR, DC-SIGN, SIGNR3, which is targeted by Leishmania infantum to inhibit 
the microbicide response mediated by the Syk-coupled CLR, Dectin-1 and the CLR, 
macrophage mannose receptor (MMR), favouring parasite resilience (Lefevre et al., 2013) (Fig. 
1.4E). 
 
Figure 1.4 Self and non-self sensing by myeloid CLRs Sensing self (A) to trigger immunity: 
necrotic cells infected with virus (for example vaccinia virus) can be detected by DNGR-1 on 
DCs (B) to promote homeostasis: self-glycoproteins recognition by DCIR prevents 
inflammation. Sensing non-self (C) to drive immunity: Dectin-1 detects β-glucan on some fungi 
(for example Candida albicans) mediating myeloid activation such as cytokine production (D) 
to promote tolerance to commensal microorganisms: recognition of surface layer proteins (Slps) 
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from Lactobacillus acidophilus by SIGNR3 contributes to mucosal barrier function (E) for 
pathogen immune evasion: upon Leishmania infantum infection, Dectin-1 and MMR induce a 
microbicide response. SIGNR3 promotes parasite survival by inhibiting this response. F-actin, 
filamentous actin; DNGR-1, DC, NK lectin group receptor-1; DCIR, dendritic cell 
immunoreceptor ; Dectin-1, dendritic cell-associated lectin-1 ; SIGNR3, specific intracellular 
adhesion molecule-3 grabbing non-integrin homolog-related 3; MMR, macrophage mannose 
receptor ; Syk, spleen tyrosine kinase;  (SHP)-1 or -2, src homology region 2 domain-containing 
phosphatase; ITAM, immunoreceptor tyrosine-based activating motif; ITIM, immunoreceptor 
tyrosine-based inhibitory motif. The symbol P indicates a phosphorylated motif.  
In light of the presented examples, we could hypothesize that activating receptors could mainly 
sense non-self ligands to trigger the immune response while ITIM-bearing CLRs could 
preferentially bind self –ligands to dampen inflammation. However, the current general view is 
that most CLRs are adaptable structures that can bind both endogenous and exogenous ligands, 
resulting in distinct functional outcomes that are not strictly determined by their intracellular 
bearing motif (Del Fresno et al., 2018 8903).  
 
1.5 The myeloid CLR Mincle is an adaptable sensor 
A good example of that adaptability is the myeloid CLR Macrophage inducible C-type lectin, 
Mincle (CLEC4E). Mincle is a classic dual receptor for both self and non-self ligands. 
1.5.1 Mincle, its origin, pattern of expression, molecular signalling and structure 
Mincle was identified in 1999, as a transcriptional target of nuclear factor interleukin-6 (NF-
IL6, also called C/EBPβ) in macrophages (Matsumoto et al., 1999). Mincle is encoded by a 
chromosome 6 gene in mouse (chromosome 12 in humans), clustered with closely related CLRs 
of the Dectin-2 family (Dectin-2, DCIR, DCAR, and BDCA-2) (Graham and Brown, 2009). 
Mincle is expressed on monocytes, macrophages, neutrophils, DCs, and some subset of B cells 
(Richardson and Williams, 2014, Matsumoto et al., 1999, Flornes et al., 2004, Behler et al., 
2015, Lee et al., 2012, Kawata et al., 2012). The expression of Mincle in the steady-state 
condition is very low; however, its expression is induced by inflammatory stimuli including 
lipopolysaccharide (LPS), tumour necrosis factor-α (TNFα), IL-6, and interferon-γ (IFNγ) 
(Matsumoto et al., 1999 , Richardson and Williams, 2014). This induction involves NF-IL6 and 
myeloid differentiation primary response 88 (MYD88) (Matsumoto et al., 1999, Schoenen et al., 
2014, Kerscher et al., 2016a). In particular, TLR4 stimulation in mouse macrophages (Lee et al., 
2012) or TLR9 stimulation in human B cells (Kawata et al., 2012), induces Mincle expression. 
In contrast, Mincle expression can be downregulated by IL-4 in a STAT-6-dependent manner, 
and LPS prevent this suppression (Ostrop et al., 2015, Hupfer et al., 2016). 
As mentioned above, Mincle is a type-II transmembrane molecule with an extracellular CRD 
motif belonging to the CLR group II (Balch et al., 1998). Extracellular ligands can bind occur at 
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distinct sites, which has been described for cholesterol, protein and the CRD interaction sites. 
Within its CRD Mincle contains an EPN motif (Glu–Pro–Asn), which suggests 
mannose/fucose/N-acetyl glucosamine/glucose specificity (Lee et al., 2011). Intracellularly, 
Mincle is an ITAM-coupled CLR that interacts through a positively charged arginine located in 
its transmembrane region with the ITAM-containing adaptor protein FcRγ chain, being this 
interaction critical for its signalling (Yamasaki et al., 2008). This receptor can form 
heterodimers with another myeloid CLR called macrophage C-type lectin (MCL;CLEC4D) 
which signals through Syk  and interacts with the adaptor FcRγ chain (Graham et al., 2012) 
(Miyake et al., 2013), but it does not contain an arginine within the transmembrane domain and 
uses Mincle to interact with the adaptor protein (Lobato-Pascual et al., 2013, Miyake et al., 
2015). The stalk region from MCL is needed for Mincle translocation to the cell surface after 
exposure to pro-inflammatory stimuli (Miyake et al., 2015). In contrast to Mincle, MCL is 
constitutively expressed by macrophages and DCs and MYD88 is critical for its surface 
translocation (Miyake et al., 2013, Kerscher et al., 2016a). Canonical Mincle signalling involves 
Syk kinase and extracellular signal–regulated kinase (Erk) activation, assembly of the ternary 
protein complex (CARD9-Bcl10-Malt1) and finally the activation of NF-kB and the expression 
of pro-inflammatory cytokines, such as TNFα, IL-6 and chemokines, such as MIP-2 (CXCL2) 
and KC (CXCL1) (Hara and Saito, 2009). 
 
1.5.2 Mincle is a multi-sensor for multiple ligands 
Several structures from both the mammalian host as well as microbes have been identified as 
ligands for Mincle. Therefore, Mincle is a classic dual sensor able to sense self and non-self 
ligands from a growing list of bacteria and fungi.  
1.5.2.1 Mincle-self-ligand recognition  
Self-ligands for Mincle include “dangerous” ligands that promote immunity and inflammation. 
For example, some forms of cholesterol, including, the crystalline form, which is present within 
atherosclerotic plaques, that promotes inflammation via human, but not rat and mouse Mincle 
(Kiyotake et al., 2015). Conversely, the cholesterol sulphate form, which is present at high 
levels in the skin, promotes allergic skin inflammation through Mincle (Kostarnoy et al., 2017) 
(Fig. 1.5A). In addition, the host intracellular glycosphingolipid β-glucosylceramide (β-GlcCer) 
can signal through Mincle promoting systemic inflammation characteristic of Gaucher’s 
disease, an inherited genetic defect in β-glucocerebrosidase (GBA1) that leads to the 
accumulation of this compound. Accordingly, GBA1–/– DCs are more potent promoting 
adaptive immune response than WT DCs, in a Mincle-dependent manner, suggesting that β-
GlcCer is an endogenous adjuvant which acts through Mincle (Nagata et al., 2017) (Fig. 1.5A).  
Thus, Mincle is a promiscuous receptor and there are “dual” self-ligands that can promote 
immunity or immunosuppression depending on the context. For example, the first self-ligand 
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identified for Mincle, the Sin3A-associated protein 130 (SAP-130). It is a component of the U2 
small nuclear ribonucleoprotein (snRNP) localized at the nucleus in normal live cells (Das et al., 
1999), and is released from necrotic cells, but not from live or early apoptotic cells. SAP-130 
binds to Mincle CRD in a distinct site than carbohydrates in Ca2+- and EPN-independent 
manner.  The interaction between Mincle and SAP130 can lead to inflammation in certain 
situations, like ischemia/reperfusion, ethanol-induced liver injury, obesity and to the 
development of experimental autoimmune uveoretinitis and hepatitis (Yamasaki et al., 2008, 
Arumugam et al., 2017, Suzuki et al., 2013, Zhou et al., 2016 , Tanaka et al., 2014, Lee et al., 
2016a, Greco et al., 2016). On the contrary, in a pancreatic tumorigenesis mouse model, Mincle-
SAP-130 interaction promotes oncogenesis mediated by the tumour-infiltrating myeloid cells-
drived immunosuppression (Seifert et al., 2016) (Fig. 1.5B). On the opposite side, the “non-
dangerous” self-ligand, albumin provokes immunosuppression through Mincle after 
subarachnoid haemorrhage (Xie et al., 2017) (Fig. 1.5C). 
1.5.2.2 Mincle non-self-ligand recognition  
Regarding non-self ligands, Mincle is able to recognize pathogens and commensals, bacteria 
and fungus. From commensals microorganisms, Mincle can recognize ligands present in some 
commensal bacteria, such as the corynomycolic acid-containing glycolipids from 
Corynebacterium (Schick et al., 2017 , van der Peet et al., 2015) and the α-glucosyl diglyceride 
from Lactobacillus plantarum (Shah et al., 2016) but how Mincle-commensals interaction 
impacts the generation of the immune response is starting to be explored (Fig. 1.5D). In 
addition, Malassezia spp., an obligatory lipophilic fungus, including M. pachydermatis and M. 
dermatis contain at least two glycolipids, glyceroglycolipid and mannosyl fatty acids linked to 
mannitol, which can act as ligands for Mincle(Ishikawa et al., 2013). Malassezia is part of the 
normal skin microbiota of many mammals (Sparber and LeibundGut-Landmann, 2017), 
although this fungus can elicit an inflammatory response in the skin lesions of patients with 
atopic/eczema dermatitis and psoriasis and can cause diseases such as tinea versicolor, atopic 
dermatitis, and lethal sepsis (Ashbee, 2006). It is described that Mincle-Malassezia interaction 
promotes immunity although the experimental approach employed, by intraperitoneal 
administration of the fungus, does not resemble its normal niche and does not provide reliable 
information on the potential role of Mincle in maintaining the commensalism. Although it is 
clear from these studies that Mincle-induced inflammation in this context may contribute to the 
regulation of dermatitis or sepsis triggered by Malassezia (Yamasaki et al., 2009, Ishikawa et 
al., 2013) (Fig. 1.5E). 
Regarding pathogens, Mincle can interact with them and mediates “direct immunity” (Fig. 1.5F, 
G), “direct immunosuppression” (Fig. 1.5H) or “indirect immunosuppression” by inhibiting 
immunity mediated by other receptors (Fig. 1.5I). From pathogenic bacteria the most studied 
ligands for Mincle are the mycobacterial glycolipids from Mycobacterium species, being the 
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trehalose-6,6-dimycolate (TDM) the best characterized one (Ishikawa et al., 2009 , Matsunaga 
and Moody, 2009). The cell wall glycolipid, TDM (initially called cord factor) is one of the 
major components of complete Freund’s adjuvant. TDM and it less toxic analogue, trehalose-
6,6-dibehenate (TDB) (Pimm et al., 1979) were shown to signal through Mincle (Ishikawa et al., 
2009, Schoenen et al., 2010).  Mincle recognition of TDM by myeloid cells favours the TDM-
induced granuloma formation and the generation of Th1/Th17 mediated immunity although 
Mincle-deficient mice form granulomas similar to WT mice and generate an adequate Th1/ 
Th17 response upon infection with M. tuberculosis (Schoenen et al., 2010, Behler et al., 2015). 
However, recent in vitro studies indicate that Mincle can also promote the expression of the 
anti-inflammatory cytokine IL-10 in response to TDM, it requires TLR-2-mediated 
simultaneous signal and leads to TLR2-induced IL-12p40 downregulation (Patin et al., 2016). In 
addition, Mincle via p38 and eukaryotic translation initiation factor 5A (eIF5A) hypusination 
increases nitric oxide (NO) leading to granuloma resolution (Lee et al., 2016b). Thus, Mincle 
seems to play a dual role in the promotion and resolution of inflammation in response to 
purified TDM, but this receptor is dispensable for the response during infection due to other 
PRR co-stimulation. Another mycolic acid derivative compound from mycobacteria, glycerol 
monomycolate, and  M. tuberculosis metabolites, β-gentiobiosyl diacylglycerides, were 
identified as a Mincle ligands, the first one only in the case of human but not mouse Mincle 
(Hattori et al., 2014 , Richardson et al., 2015) (Fig. 1.F,H).  Klebsiella pneumoniae (Sharma et 
al., 2014), Streptococcus pneumoniae (Rabes et al., 2015, Behler-Janbeck et al., 2016), 
Tannerella forsythia (Chinthamani et al., 2017), Pneumocystis (Kottom et al., 2017) are other 
reported pathogenic bacteria that through Mincle promote immunity against these pathogens 
although the specific ligands that bind Mincle are unknown, only in the case of  diacylglycerol 
from S. pneumonia (Behler-Janbeck et al., 2016) (Fig. 1.5F). Instead of promoting immunity, 
Helicobacter pylory recognition by Mincle generates an anti-inflammatory response, being this 
receptor employed by H. pylori to escape clearance by host immune system (Devi et al., 2015) 
(Fig. 1.5H). 
Regarding pathogenic fungus, as mentioned for pathogenic bacteria, most of the specific ligands 
that bind Mincle are yet unidentified. Candida albicans (C. albicans) was suggested to contain 
ligands for Mincle, although controversy exists between studies performed with different strains 
of C.albicans. Candida-Mincle interaction contribute to the inflammatory response against the 
fungal infection (Bugarcic et al., 2008, Wells et al., 2008, Yamasaki et al., 2009)(Fig. 1.5G). In 
contrast, Mincle recognition of pathogenic fungus, Fonsaeca pedrosoi the causal agent of the 
chromoblastomycosis, a chronic skin infection, is not sufficient for host control of the infection. 
This interaction results in high levels of IL-10 and low level of TNF-α and IFN-γ only reverted 
by TLR co-stimulation (Sousa Mda et al., 2011). Interestingly, another myeloid CLR, Dectin‐2, 
the receptor is involved in the generation of fungus‐specific Th17 cells, whereas Mincle inhibits 
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this response (Wuthrich et al., 2015) (Fig. 1.5H). Similarly, this Mincle-mediated “indirect 
immunosuppression” of heterologous receptors occurs in response to Fonsecaea monophora. 
Dectin-1 and Mincle are involved in the recognition of this fungus. Dectin-1 initiates protective 
immunity by activating the transcription factor, interferon regulatory factor 1 (IRF1), crucial for 
IL12A transcription, which is dampened by Mincle activation. Mincle-Syk-CARD9-PKB 
pathway-dependent activation of the E3 ubiquitin ligase mouse double minute two (Mdm2) 
leads to nuclear IRF1 degradation, blocking IL12A transcription (Wevers et al., 2014) (Fig. 
1.5H).  Altogether, these examples illustrate how Mincle deals with self and non-self ligands 
resulting in activating or inhibitory signals. However, the correlation of sensing self with an 
inhibitory response and sensing non-self with an activating response is not established. In this 
regard, non-self signals from pathogens may mimic self-inhibitory signals to escape immune 
surveillance and non-self ligands recognition in the context of commensals can promote 
immune tolerance instead of immunity. 
Figure 1.5 Mincle is a flexible receptor for multiple ligands. (A) Dangerous-self ligands 
include cholesterol crystals or sulphate, and β-GlcCer that promote inflammation; (B) Dual-self 
ligands, SAP-130 can either promote inflammation (ischemia/reperfusion, obesity, uveoretinitis) 
or immunosuppression (cancer) depending on the context; (C) Non-dangerous-self ligands such 
as the albumin drives immunosuppression. (D, E) Commensal non-self ligands present in  
bacteria and fungi, such as Corynebacterium, Lactobacillus, or Malassezia  can be recognized 
by Mincle, although the triggered response has neither been explored yet (D), nor addressed in 
the proper context (E). (F-I) Pathogen-derived ligands can either directly promote immunity 
against pathogenic bacteria (F) or fungi (G), or directly promote immunosuppression by 
inducing an anti-inflammatory response (for example IL-10 secretion by myeloid cells) (H), or 
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indirectly drive immunosuppression by dampening the inflammatory signalling from 
heterologous CLRs (I). β-GlcCer, β-glucosylceramide; SAP-130, Sin3-associated protein 130; 
FcRγ, Fc receptor γ; CLRs, C-type lectin receptors.  
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2. OBJECTIVES 
The general objective of this thesis is to investigate the dual role of the myeloid Syk-coupled 
CLR Mincle during recognition of non-self ligands derived from either pathogenic or 
commensal microorganisms. The specific objectives are the following: 
 
1. Analyse the role of Mincle in the Leishmania major-induced immune response (see also 
4.1.1 Specific introduction (I) FIG.4.1.1): 
 
 Explore whether Leishmania contains a ligand for the CLR Mincle. 
 Characterize the Mincle-Leishmania- induced intracellular molecular pathway. 
 Analyse the contribution of Mincle-Leishmania interaction to DC activation and 
migration. 
 Determine the impact of Mincle-mediated DC modulation in the generation of the 
Leishmania-specific adaptive immunity. 
 
 
2. Analyse the role of Mincle in the regulation of intestinal homeostasis of commensals (see 
also 4.2.1 Specific introduction (II) FIG.4.2.1): 
 Study the presence of Mincle ligands in the intestinal commensal microbiota. 
 Characterize intracellular molecular pathway induced by detection of microbiota by 
Mincle. 
 Analyse Mincle expression in the intestinal myeloid cells. 
 Role of Mincle-microbiota interaction in DC activation. 
 Effect of Mincle-mediated DC modulation in the generation of the Th17 cells and ILCs 
functionality in response to microbiota. 
 Investigate how Mincle-microbiota interaction contributes to the maintenance of the 
mucosal barrier function. 
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3. MATERIALS & METHODS 
3.1 Mice 
Mouse colonies were bred at the CNIC under specific pathogen-free (SPF) conditions. Colonies 
included Clec4e-/- (B6.Cg-Clec4etm1.1Cfg) mice backcrossed more than 10 times to C57BL/6J-
Crl were kindly provided by the Scripps Research Institute, through R. Ashman and C. Wells 
(Griffiths University, Australia) (Wells et al., 2008). CD11c∆Syk (Iborra et al., 2012) and 
Clec4e-/- mice were generated along with WT littermates by heterozygous mattings when was 
required. Fcer1g-/- (B6; 129P2-Fcer1gtm1Rav/J) from The Jackson Laboratory (Takai et al., 
1994), CD11c∆SHP1 (Abram et al., 2013) and OT-II CD4+ TCR transgenic mice in C57BL/6 
background (B6.Cg-Tg (TcraTcrb) 425Cbn/J) were from The Jackson Laboratory. OT-II mice 
were mated with B6/SJL expressing the CD45.1 congenic marker to facilitate cell tracking. 
Rorc-/- mice and Aicda-/- mice were kindly provided by Dr. B. Becher (UZH, Switzerland) and 
Dr. A. Ramiro (CNIC, Spain), respectively. Animal studies were approved by the local ethics 
committee. All animal procedures conformed to EU Directive 2010/63EU and Recommendation 
2007/526/EC regarding the protection of animals used for experimental and other scientific 
purposes, enforced in Spanish law under Real Decreto 1201/2005. 
 
3.2 Leishmania species, parasite preparation, inoculation, and quantification 
In vivo experiments were carried out using different Leishmania major (L. major) lines: L. 
major Friedlin strain FV1 (MHOM/IL/80/ Friedlin) was generously provided by Dr. D. Sacks 
(NIH) (Iborra et al., 2011). L. major FV1 (MHOM/IL/80/ Friedlin) parasites expressing 
ovalbumin (Leishmania-OVA) were kindly provided by Prof. Deborah Smith and Prof. Paul 
Kaye (University of York) (Prickett et al., 2006). Recombinant L. major LV39c5 
(RHO/SU/59/P) parasites expressing the red-fluorescent protein mCherry (mCherry+ L. major) 
were described previously (Calvo-Álvarez et al., 2012). L. amazonensis (IFLA/BR/67/pH.8), L. 
braziliensis (MHOM/BR/75/M2904), L. donovani (MHOM/IN/83/Dd8), and L. tropica 
(MHOM/SU/74/K27) were generously provided by Dr. J. Moreno (IS Carlos III, Spain). L. 
infantum (MCAN/ES/96/BCN150) was kindly provided by Dr. L.C. Gómez-Nieto (UNEX, 
Spain). For Leishmania challenge, parasites of different lines were cultured and kept in a 
virulent state as described (Martinez-Lopez et al., 2015). Mice were infected by intradermal 
(i.d) inoculation of 1×103 or 5×104 metacyclic L. major promastigotes into the dermis of both 
ears (Martinez-Lopez et al., 2015). Lesion size in the ear and number of viable parasites was 
determined as described (Martinez-Lopez et al., 2015). The parasite load is expressed as the 
number of parasites in the whole organ. 
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3.3 Parasite preparation of protein extracts and binding to Mincle-hFc chimera 
For preparation of soluble Leishmania extract (SLA), approximately 109 promastigotes were 
harvested and washed twice in phosphate buffer saline (PBS). After 3 cycles of freezing and 
thawing, the suspension was centrifuged at 13,000xg for 20 minutes at 4°C, and supernatant 
containing SLA was stored at −80°C. Protein concentration was estimated by the Bradford 
method. Freeze-thawed L. major parasites were prepared by 3 cycles of freezing and thawing of 
108 stationary parasites in complete RPMI medium or PBS. Fixed and permeabilized 
Leishmania parasites were prepared by fixing 108 parasites with 0.5 ml of 4% paraformaldehyde 
(PFA) and immediate addition of 0.5 ml 1% NP-40. After incubation for 10 minutes at room 
temperature (RT), parasites were washed with PBS. To obtain culture supernatants, stationary 
promastigotes were washed 3 times in PBS, suspended at 5x108 parasites/ ml in serum free 
DMEM, and incubated for 3 hours at 37º C. Culture supernatants were collected by two steps of 
centrifugation, first at 1,500×g for 5 minutes at 4 °C, followed by a second step at 2,500×g for 
10 minutes. Protein concentration was estimated by the Bradford method.  
For dot-blot determination of Mincle ligands in Leishmania extracts, protein samples were 
applied to 0.2 µm membranes (BioRad) using a vacuum dot blot apparatus (BioRad). To load 
different protein amounts in each dot, protein samples were serially diluted in PBS (1:3). 
Similarly, for ELISA, high-binding plates were loaded with protein samples serially diluted in 
PBS (1:3). Plates were incubated for 24 hours at 4ºC. Later, membranes and plates were washed 
with PBS and incubated with blocking solution (2% defatted milk in PBS) for 120 minutes at 
RT, followed by incubation with Mincle-hFc chimera or control-hFc (2µg/ml) for 2 hours. 
Membranes and plates were then incubated with anti-human IgG (Fc gamma-specific) 
conjugated to biotin. Membranes were imaged with the LI-COR Odyssey Infrared Imaging 
System. 
 
3.4 Generation and assay of B3Z cell lines expressing Mincle and FcRγ chain mutants 
B3Z cells (kindly provided by N. Shastri, University of California) express a β-gal reporter for 
nuclear factor of activated T cells (NFAT) (Karttunen et al., 1992). B3Z cells were transduced 
with retroviruses expressing FcRγ chain, Syk and mouse Mincle. FcRγ chain ITAM tyrosine 65 
and 76 phenylalanine mutants were generated using the QuickChange lightning site-directed 
mutagenesis kit (Agilent). Binding of ligands can be detected by NFAT reporter activation and 
induction of β-gal activity. B3Z cells were plated in 96 well plates and incubated with plated 
Trehalose-6,6-dibehenate (TDB) or anti-Mincle (clone 1B6) in the presence or absence of 
Leishmania extract. Lysed parasites used in B3Z assays were opsonized with fresh serum from 
infected Balb/c mice for 2 hours at RT and washed twice with PBS. Before B3Z cell plating, 
promastigotes were seeded on plates coated with 50 µg/ml poly-L-Lysine (Sigma), for 30 
minutes at 37 ºC. After overnight (O/N) culture, cells were washed in PBS, and LacZ activity 
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was measured by lysis in CPRG (Roche)-containing buffer. Four hours later O.D.595 nm was 
measured relative to O.D.655 nm used as a reference. 
 
3.5 Western blot analysis and immunoprecipitation 
For immunoblotting, 1x106 CD11c+ GM-cells were seeded in 24 well plates for 4 hours in serum 
free RPMI and stimulated with dead Leishmania at a 10:1 parasite: GM-cell ratio. For 
immunoprecipitation, 1x107 CD11c+ GM-cells or 3x107 B3Z cells were stimulated with dead 
Leishmania at 5:1 ratio. After stimulation, cells were washed and suspended in Triton X-100 
(TX-100) lysis buffer (50 mM Tris-HCl pH 7.5, 1mM EGTA, 1mM EDTA pH 8.0, 50mM NaF, 
1mM sodium glycerophosphate, 5mM pyrophosphate, 0.27 M sucrose 0.5 % Triton X-100, 
0.1mM PMSF, 0.1% 2-mercaptoethanol, 1mM sodium orthovanadate, and protease inhibitor 
cocktail (Roche)). After incubation on ice for 15 minutes, nuclei were pelleted by centrifugation 
for 15 minutes (1,300xg, 4°C). For immunoprecipitation assays, cell extracts were incubated 
O/N with dynabeads® bound to 2 µg anti-mouse SHP1 (rabbit polyclonal; Santa Cruz C-19), or 
4 µg anti-HA (Miltenyi). After pull-down, beads were washed twice in ice-cold lysis buffer and 
eluted by boiling in SDS sample buffer. Cytosolic protein extracts or immunoprecipitated 
proteins were separated by SDS–PAGE and transferred onto nitrocellulose membrane (Bio-Rad 
Laboratories). After blocking with 5% bovine serum albumin (BSA, fraction V, Sigma), 
membranes were incubated O/N with antibodies to phospho-SHP1 (Tyr564; #8849), SHP1 
(#3759), phospho-Syk (Tyr525/526; #2711), Syk (#2712) (Cell Signaling Technology); SHP1 
(Santa Cruz, sc-7289); Mincle (Clone 1B6); or Fcer1g (antibodies online, RB41735). 
Membranes were imaged with the LI-COR Odyssey Infrared Imaging System. 
 
3.6 FITC skin sensitization migration assay 
Mice were inoculated in the left ear with PBS and in the right ear with L. major parasites 
(5×104). Ears were painted 16 hours or 14 days later with 1% FITC (Sigma-Aldrich) prepared in 
an inflammatory stimulating solution of acetone and dibutyl-phthalate (1:1, vol:vol) as 
previously described (Macatonia et al., 1987). Retromaxillary draining lymph nodes (dLNs) 
were harvested 24 hours after painting, and LNs cells were analyzed by flow cytometry. 
 
3.7 Flow cytometry, quimeras generation and antibodies 
Samples for flow cytometry were stained in ice-cold PBS supplemented with 2mM EDTA, 1% 
fetal bovine serum (FBS), 0.2% sodium azide (FACs buffer) and the appropriate antibody 
cocktails (See also Table-3.1 for antibodies details). Purified anti-FcγRIII/II (2.4G2) or or anti 
human Fc block (Becton Dickinson) was used to block unspecific antibody binding towards 
murine or human cells, respectively. Non cell-permeant Hoechst 33258 (0.1 µM) was used as a 
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counterstain to detect necrotic cells while human dead cells were excluded from the analysis 
using a live/dead fixable near-infrared dead cell stain kit (Molecular Probes). Data was acquired 
on a LSR Fortessa (BD Biosciences) and analyzed with FlowJo software (TreeStar). 
For generation of the recombinant human Mincle-hFc chimera, the cDNA encoding human 
Mincle extracellular domain (amino acid residues 46-219 Swiss-Prot Accession number 
Q9ULY5) was optimized for mammalian expression and synthesized by Life Technologies. 
Cysteine residue 52 was replaced by serine to reduce the level of disulphide-linked aggregation 
seen with the wild type sequence. The cDNA fragment was cloned into the mammalian 
expression destination vector pDEST12.2 (Invitrogen). The expression vector had been 
modified to contain regions encoding an N-terminal polyhistidine (His10) and human Fc tag. 
Mincle-hFc protein was directed for secretion into the medium by the inclusion of a CD33 
signal sequence. Human Mincle-hFc was expressed in suspension-adapted CHO cells using 
polyethylenamine (Polysciences) as the transfection reagent. Recombinant Mincle fusion 
protein was purified from culture supernatant using Protein A (HiTrap Protein A HP column; 
GE Healthcare) affinity chromatography followed by size exclusion chromatography (Superdex 
75 column; GE Healthcare). Mouse Dectin-1-Fc was generated by cloning the EcoRI-NotI 
fragment of the PCR product into the EcoRI-NotI sites of the pSecTag.Fcmut vector, which 
couples to human IgG1 Fc (See Table 3.2 for primers sequence). Human IgG1-hFc control 
was from Abcam. 
3.8 Mouse cell isolation and purification 
At the indicated times after Leishmania major (L. major) infection, ears were harvested from 
naive or infected mice. The ventral and dorsal sheets of the infected ears were separated and 
placed in RPMI containing 50 µg/ml Liberase CI enzyme blend (Roche). After 90 minutes at 
37°C, the tissues were cut into small pieces and homogenized. Retromaxillary LNs were 
removed and mechanically dissociated using tweezers and a syringe plunger. Tissue 
homogenates were filtered through a 70 µm cell strainer (Falcon Products).  
Small intestine lamina propria (LP) cells were isolated as previously described (Goodyear et al., 
2014). Briefly, small intestine was opened longitudinally and washed with HBSS (Thermo 
Fisher Scientific), cut and placed into HBSS 5 mM DTT (Sigma Aldrich). Next, tissues were 
washed 3 times with HBSS 2 % FBS, 5 mM EDTA, minced into fine pieces and digested in 
HBSS supplemented with 0.2 Wünsch units/ml Liberase TM (Sigma-Aldrich) and 200 
Kunitz/ml DNase I (Biomatik). Cells were passed through a 70 μm cell strainer and washed 
with RPMI complete medium supplemented with 20 % FBS, 2 mM L-glutamine, 100 U/ml 
penicillin, 100 μg/ml streptomycin, 50 μM 2-mercaptoethanol.  
In the indicated experiments, liver cell dissociation was performed as previously described 
(Allen et al., 2017). Briefly, liver was perfused through the heart with 20 ml of PBS. The liver 
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was extracted, minced into fine pieces and digested in HBSS containing 0.5 mg/ml of type IV 
Collagenase from Clostridium histolyticum (Sigma Aldrich) and 40 µg/ml DNase I (Biomatik) 
during 20 minutes at RT. The digestion was stopped with FBS. The cells were filtered through a 
70 μm cell strainer and centrifuged at 54xg 2 minutes at 4ºC.  The supernatant was collected and 
centrifuged at the same speed two times. The final supernatant (non-parenchymal cells) was 
centrifuged at 300xg 10 minutes at 4ºC and use for flow cytometry analysis. 
Spleen and skin-LNs or Peyer´s Patches (PPs) (5 per mouse/ 3 mice per sample) collected in 
RPMI complete medium were mechanically dissociated using tweezers and a syringe plunger. 
Tissue homogenates were filtered through a 70 μm cell strainer. In indicated experiments, PPs 
were digested as described (Bonnardel et al., 2015b) using 100 μg/ml of type 2 collagenase 
from Clostridium histolyticum (Worthington Biochemical Corporation) and 140 μg/ml of 
DNase I (Biomatik)  for 40 minutes at RT and myeloid cells were enriched by negative 
selection using a cocktail of biotin-conjugated antibodies (anti-CD3, CD19, Biolegend) and 
Streptavidin-microbeads (Miltenyi Biotec). 
Where further purification of naive CD4+ T cells from spleen and lymph nodes was required, 
cells were first enriched by negative selection using a cocktail of biotin-conjugated antibodies 
(anti-CD11c, CD11b, B220, MHC-II, CD8, GR1, CD16/32, BD Bioscience) and Streptavidin-
microbeads (Miltenyi Biotec) and then sorted based on expression of CD44 and CD62L using a 
FACs Aria cell sorter. DCs from LNs and ears were purified with anti-CD11c-microbeads 
(Miltenyi Biotec).  Where indicated, cells were labelled with CellTracer Violet (5 µM, Thermo 
Fisher Scientific). Dome CD11b+, CD8α+ DCs, LysoDCs and LysoMacs from PPs and CD3+ T 
cells or CD3- CD90.2+ ILCs from small intestine LP were purified using the FACs Aria cell 
sorter. 
 
3.9 Human Leishmania-infected spleen or skin and healthy human intestinal samples 
Human samples of Leishmania-infected spleen or skin were collected from the BioB-HVS 
biobank and were used for Mincle expression analysis by immunohistochemistry or 
immunofluorescence, respectively. Human intestinal samples were obtained from healthy 
controls with no known autoimmune diseases or malignancies who had been referred to the 
endoscopy unit for screening of gastrointestinal diseases, although in all cases they had 
macroscopically and histologically normal (non-inflamed) intestines. Samples were obtained 
following informed consent after ethical approval (BER-CDEII-2015) from Hospital 
Universitario de La Princesa (Madrid, Spain). Biopsies were collected in ice-chilled complete 
medium and processed immediately in the laboratory by incubating them twice in HBSS 
containing 1 mM DTT and 1 mM EDTA for 30 minutes at 37ºC with 250 rpm rotation. 
Intestinal biopsies were then digested in RPMI supplemented with 1 mg/ml of collagenase D 
(Roche) for a maximum of 90 minutes at 37ºC with 250 rpm rotation. Intestinal LP cells were 
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then passed through 100 μm cell strainers (Fisher) and washed in FACS buffer (ice-cold PBS 
supplemented with 2.5 mM EDTA, 5 % FBS, 0.2% sodium azide) before proceeding with the 
antibody staining. 
 
3.10 M-CSF and GM-CSF Bone Marrow-derived cells generation, purification and 
stimulation 
Bone-marrow-derived macrophages (BMDM) from the indicated genotypes were obtained from 
bone marrow cell suspensions after culture on non-treated 60-mm Petri dishes in complete 
RPMI medium supplemented with 20% FBS, 2 mM L-glutamine, 100 U/ml penicillin, 100 
μg/ml streptomycin, 50 μM 2-mercaptoethanol, and 30% supernatant of the M-CSF-producing 
cell line L929. On day 7, preparations of BMDM, characterized as CD11b+ F4/80+ cells, were 
>95% pure. Cell suspensions from bone marrow of the indicated genotypes including WT, 
Myd88-/- (Adachi et al., 1998), CD11cΔSyk (Iborra et al., 2012), CD11c∆SHP1 (Abram et al., 
2013), Fcer1g-/- (B6; 129P2-Fcer1gtm1Rav/J) (Takai et al., 1994), Clec7a -/- (Marakalala et al., 
2013), Clec4n-/- (Saijo et al., 2010) and Clec4e-/- (Wells et al., 2008) were cultured  on non-
treated 150-mm Petri dishes as described (del Fresno et al., 2013) for Leishmania studies  tissue 
culture flasks (Falcon Products) for microbiota studies, both in the presence of 20 ng/ml 
recombinant GM-CSF (Peprotech). GM-CSF BM-derived cells were collected on day 8 and 
purified by positive selection with anti-CD11c-microbeads (Miltenyi Biotec).  
GM-CSF BM-derived CD11c+ cells (GM-BM, 2x106/ml) were stimulated by co-culture with 
serial dilutions of freeze-thawed (F/T) L. major, LPS EB (100 ng/ml, InvivoGen), plated TDB 
(1 µg/well, InvivoGen), zymosan (10 µg/ml, InvivoGen) or by co-culture with the indicated 
ratio of total microbiota from SPF mice (quantified by the optical density at 600 nm (OD600 nm) 
together with quantification by flow cytometry) in the presence of 100 U/ml Penicillin and 100 
μg/ml Streptomycin.   
Activation of GM-BMs was assessed by quantifying the upregulation of MHCII, CD40, CD86, 
CCR7, Syk phosphorylation and/or cytokine release measured by ELISA. In the indicated 
experiments, the stimulation of GM-CSF BM-derived CD11c+ cells was done in the presence of 
SHP1/2 phosphatase inhibitor (5 or 10 µM, NSC-87877, Calbiochem). 
For some experiments, GM-BMs were FACS-sorted based on the expression of MERTK and 
CD115 into conventional DCs (GM-DCs) and monocyte-derived macrophages (GM-Macs)  as 
previously described (Helft et al., 2015). 
 
3.11 Transduction of GM-CSF BM-derived cells with lentiviruses 
MCL and its mutant genes were introduced into the CSII- CMV-MCS-IRES-Bsd expression 
vector. Human embryonic kidney (HEK) 293T cells were transfected with the expression vector 
together with packaging vectors (pCMV-VSV-G-RSV-Rev and pCAG-HIVgp). Culture 
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supernatant was collected at 48–72 hours after transfection. Virus was concentrated by 
ultracentrifugation at 50,000×g for 2 hours at 20 ℃. For transduction, WT, Mincle-deficient or 
MCL-deficient GM-BM cells were incubated with lentivirus at a multiplicity of infection 
empirically determined for each lentivirus that yield to successful transduction tested by 
blasticidin S resistance, together with 20 µl of DOTAP liposomal transfection reagent (Sigma-
Aldrich). After 16 hours, the medium was replaced with fresh culture medium. Lentivirus-
infected cells were selected by culture with 10 µg/ml blasticidin S for 3 days.  
 
3.12 Immunofluorescence and in vivo imaging 
For immunofluorescence of intestinal mucus or promastigotes and L. major-infected 
macrophages were adhered to coverslips coated with poly-L lysine (50µg/ml, Sigma) O/N at 
4ºC or during 30 minutes at 37ºC, respectively. Coverslips were washed in PBS, and the mucus 
or the cells were then fixed in 2% PFA in PBS for 10 minutes at RT, washed with PBS, and 
permeabilized with 0.1% TX-100 in PBS solution for 10 minutes in the case of the 
promastigotes and L. major-infected macrophages. Preparations were then incubated with 
blocking solution (2% skimmed milk, with 0.1% TX-100 in PBS for Leishmania or without TX-
100 for mucus analysis) for 60 minutes at RT and stained with Fc ectodomains and 
counterstained with DAPI in the indicated experiments to reveal nuclei and kinetoplasts. 
Finally, samples were covered with ProLong Gold Antifade Reagent liquid mountant (Life 
Techologies) and visualized under a Zeiss LSM 700 confocal microscope or by using a Leica 
SP8 STED super resolution microscope as indicated. 
For immunofluorescence of phospho-Syk (P-Syk), purified CD11c+ GM-BM cells were adhered 
to coverslip and fixed with Fixation/Permeabilization Solution Kit (BD biosciences) after 
stimulation. Anti-P-Syk (Clone C87C1) antibody from Cell Signaling was added and incubated 
at 4°C O/N. Samples were washed and anti-P-Syk was detected using the tyramide signal 
amplification kit (TSA detection kit Alexa Fluor 568, Molecular Probes) as recommended by 
the manufacturer. For Mincle expression analysis, PPs whole mount preparations were done as 
described (Rios et al., 2016) and stained with anti-CD11c antibody (Clone 3.9, Abcam), biotin 
anti-mouse Mincle (Clone 1B6, MBL Life Science), PE labelled anti-CD11b (Clone M1/70, BD 
biosciences) Alexa Fluor 647 Chicken Anti Mouse IgG (H+L) (Molecular Probes), Alexa Fluor 
488 Streptavidin (Thermo Fisher Scientific) and DAPI. The samples were fixed, covered as 
described and visualized using a Zeiss LSM 780 confocal microscope. Finally, anti-human 
Mincle antibody (Clone 1B6) was used on sections of human samples of Leishmania infantum-
infected skin. 
The IVIS Spectrum in vivo imaging system (Perkin Elmer) was used to determine the evolution 
of parasitemia in real time. Mice were inoculated i.d. in the ear with mCherry+ L. major (5 x 
104), and fluorescence emission was tracked as described (Calvo-Álvarez et al., 2012). 
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mCherry+ L. major-infected animals were lightly anesthetized with isoflurane placed in the 
camera chamber, and the fluorescence signal was acquired for 3 seconds. Fluorescence 
determinations were recorded using the Xenogen in vivo imaging system 100. To quantify 
fluorescence, a region of interest was outlined and analyzed using the Living Image Software 
Package (version 2.11, Xenogen). Results are expressed as average radiance (photons/s/sr/cm2). 
 
3.13 Cell stimulation, antigen presentation in vitro and intracellular cytokine detection 
For intracellular cytokine analysis , T cells  from ears and/or ear LNs were restimulated by 
incubation for 6 hours over plated anti-CD3 (2C11,10 µg/ml) in the presence of soluble anti-
CD28 (37.51, 5 µg/ml), and brefeldin A (Sigma, 5 g/ml) added for the last 4 hours of culture.  
For sorted T cells or ILCs from the small intestine LP analysis, the cells were stimulated with 
PMA (Sigma Aldrich, 100 ng/ml) and ionomycin (Sigma Aldrich, 500 ng/mL) for 4 hours, in 
the presence of brefeldin A in the last 3.5 hours (5µg/ml). Cells were then stained with the 
corresponding surface antibodies, fixed with 4 % PFA, and incubated with anti-IL-17, anti-IL-
22 or anti-IFN-γ during permeabilization with 0.1% saponin.  
For in vitro Th17 priming, splenic naive CD4+ cells were purified using MACS technology 
(Miltenyi Biotec) according to manufacturers' instructions. 104 CD4+ cells were incubated with 
plate-bound anti-CD3 (1µg/ml) as well as soluble anti-CD28 (2 µg/ml), anti-IFN-γ (10 µg/ml), 
anti-IL-4 (10 µg/ml), TGF-β (2 ng/ml), IL-6 (5 ng/ml) and IL-23 (20 ng/ml). All recombinant 
cytokines used in this assay were from Biolegend. IL-17A and IL-22 production was assessed 
after 5 days by flow cytometry.  
FACS-sorted Dome CD11b+, CD8α+ DCs, LysoDCs and  LysoMacs from PPs (5 × 103), GM-
DCs and GM-Macs (5 × 104) or  MACS-purified GM-CSF BM-derived CD11c+ cells (1 x105) 
were co-cultured with FACS-sorted Celltrace Violet-labelled naive CD4+CD62L+ CD44- OT-II 
T (5x103 or 5 x104, respectively), and chicken ovalbumin peptide (OVA323-339, 100 μM) in 
200 μl RPMI complete medium in 96-well round-bottom plates. GM-CSF BM-derived CD11c+ 
cells, GM-DCs and GM-Macs were loaded previously with mucosa-associated commensals at a 
10:1 ratio, in the presence of 100 U/ml penicilin, 100 μg/ml streptomycin and 50 μg/ml 
gentamycin. After 72h, cell proliferation was analyzed by Celltrace Violet dilution (flow 
cytometry) and supernatants assessed for IL-17 or IFN-γ quantification by ELISA. For re-
stimulation, cells harvested after 72 h of primary culture were stimulated with PMA and 
ionomycin for 6 h (intracellular cytokine detection) in the presence of brefeldin A in the last 4 
hours of culture. Cells were stained for CD4, fixed with 4% PFA, and incubated with anti-IL-
17, anti-IL-22 or anti-IFN-γ during permeabilization with 0.1% saponin. 
For antigen presentation in vitro analysis, CD4+ OT-II cell violet-labelled  transferred mice LNs 
were removed and cell suspensions were prepared and seeded in the presence of 10 µm I-Ab-
restricted OVA peptide (323-339) and brefeldin A. LN cells were stained and analyzed by 
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intracellular flow cytometry. In some experiments, T cells were purified from retromaxillary 
LNs of infected and healed mice and co-cultured with DCs enriched form dLNs of mice 
infected 48 hours before. IFN-γ release was determined in culture by ELISA. For the detection 
of the release of IFN-γ and IL-10 specific for Leishmania antigens, 3 × 106 cells from dLNs 
were seeded in 48-well plates at 37ºC for 72 hours in the presence or absence of SLA (12 µg/ 
ml). Cytokine release was measured in culture supernatants by ELISA 
For intracellular IL-12p40 and IL-6 staining in vivo, mice were intraperitoneally inoculated with 
brefeldin A (125μg/mouse). PPs were recovered 12 h after brefeldin A injection. The cells 
obtained were fixed and permeabilized and were stained with PE conjugated anti-IL-12p40 
antibody (eBioscience) or APC anti-mouse IL-6 antibody or its isotype control antibody APC 
Rat IgG1, κ (Biolegend). 
 
3.14 Leishmania, total or mucosa-associated commensals preparation and binding studies  
To characterize the nature of the Leishmania ligand for Mincle, SLA and TDB were plated on 
ELISA plates, treated with different concentrations of NaIO4 (Sigma) and degradation agents 
(Proteinase K, 50 µg/ml; trypsin, 0.05%; DNase I, 0.1 mg/ml), and tested with Mincle-Fc or 
human IgG1Fc. SLA was conjugated to APC using Lightning-Link® APC technology (Innova 
Biosciences), and adhesion to cellular Mincle on B3z cells was analyzed by flow cytometry. 
For total microbiota analysis, fresh content from the whole intestine, except caecum, of SPF or 
germ free (GF) mice was collected from mice with ad libitum access to food and water.  For 
mucosa-associated commensals isolation, SPF mice or mice treated with antibiotics in utero 
until the weaning and gavaged with Lactobacillus plantarum (L. plantarum) were starved for 18 
hours prior to collecting the mucus by gentle scraping of the epithelium from the small intestine 
as previously described (Cohen and Laux, 1995). In both cases, the samples were vortexed, 
filtered by 70 µm filter, centrifuged at 600xg 1 minute to remove large particles, the supernatant 
was centrifuged at 13000xg for 3 minutes and the pellet was diluted in to an OD600nm of 0.6 or 
count by flow cytometry by using Bacteria Counting Kit (Thermo Fisher Scientific) as 
described (Veal et al., 2000). The analysis by flow cytometry was done as previously described 
(Eriksson et al., 2013). Mincle-hFc, Dectin-1-hFc generated as described, Dectin-2-hFc or 
Mincle-hFc (R&D Systems) and control-hFc (R&D Systems) were prepared in 10 % skimmed 
milk in PBS, were incubated O/N at 4ºC on a rotating wheel, washed three times and labelled 
with PE-conjugated goat anti-hFc antibody (eBioscience). SYTO 61 red fluorescent nucleic acid 
stain (Life Technologies) at 2.5 mM was then incorporated and washed three time in PBS. For 
IgA-coated bacteria analysis, anti-mouse IgA PE (eBioscience) was added together with SYTO 
61 red fluorescent nucleic acid stain. 
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For Mincle-hFc bound bacteria purification, anti-hFc stained bacteria were incubated with anti-
PE microbeads (Miltenyi), washed twice and then purified. After MACS separation, part of the 
negative and the positive fractions were collected for 16S sequencing analysis. 
For blocking experiments with Leishmania and commensal microbes, human Mincle-Fc 
chimera was blocked with anti-human Mincle 2F2 clone; isotype matched antibody (clone MID 
15B4, rat IgM) was used as a control (Sigma Aldrich) or with TDB (InvivoGen) prior staining 
assay.  
 
3.15 CellTracer Violet Labelling of Lactobacillus plantarum 
L. plantarum (ATCC14917) was grown O/N on MRS Broth medium (Oxoid) at 37°C in aerobic 
conditions to approximately OD600nm of 0.5. Bacteria were labelled with CellTracer Violet (100 
µg/ml, Thermo Fisher Scientific). Bacteria were incubated 10 minutes at 30ºC with constant 
agitation, washed twice and inoculated by gavage in SPF WT mice starved for 18 hours and 
previously intraperitoneally injected with 3 mg of cimetidine HCl (Sigma Aldrich) and 0.02 mg 
of sincalide (Tebu-bio). The mucosa associated commensals were collected 6 hours later for 
flow cytometry analysis. 
 
3.16 RNA isolation and quantitative RT-PCR 
Total RNA from the liver parenchymal fraction, small intestine, ileum or PPs was isolated using 
Trizol (Thermo Fisher Scientific) in combination with RNeasy Mini Kit (Qiagen) accordingly to 
manufacturer´s instructions.  RNA was reverse transcribed to cDNA using random hexamers 
and High Capacity cDNA Reverse Transcription Kit (Applied Byosystem). Quantitative PCR 
amplification was performed with the GoTaq qPCR Master Mix (Promega) in a 7900HT Fast 
Real-Time PCR System (Applied Byosystem). All reactions were done in triplicate, following 
the manufacturer’s instructions. Data were normalized to Gadph or bactin indicated in each case 
and displayed as relative values. PCR primers used for SYBR Green assays are shown (See 
Table 3.2 for primers sequence). 
 
3.17 Enzyme-linked immunosorbent assays (ELISA) 
IL-17 or IFN-γ levels were determined using the mouse IL-17A (homodimer) ELISA Ready-
SET-Go (Affymetrix) or the mouse IFN-γ ELISA Set (BD OptEIA™) according to the 
manufacturer's instructions. IL-23 and IL-6 were quantified using matched antibody pair 
ELISA. Anti-mouse IL-23 p19 (5B2) together with biotinylated anti-mouse IL-12/IL-23 p40 
(C17.8) both from Thermo Fisher Scientific. Anti-Mouse IL-6 (MP5-20F3) (BD Biosciences) 
with biotinylated anti-mouse IL-6 (MP5-32C11) (Thermo Fisher Scientific). The rest antibody 
pairs (IL12p40, IL-6, IL-10 and TNF-α) were from BD, and ELISAs were performed according 
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to the manufacturer's instructions. For the later pairs, ELISAs were developed using 
extravidin®-alkaline phosphatase and pNPP alkaline phosphatase substrate from Sigma. 
To measure total IgA, the plates were coated with goat anti-mouse IgA antibody (Bethyl 
Laboratories Inc) and the standard curve done by using purified mouse IgA, κ isotype control 
(BD Pharmingen) as previously described (Bunker et al., 2015). To analyse serum commensal 
bacteria-specific IgG, intestinal bacteria were prepared to coat ELISA plates, after heat-killing 
at 85ºC for 1 hour, following a modified protocol from the previously described (Zeng et al., 
2016). The plates were washed 3 times with PBS containing 0.05 % Tween 20 and blocked with 
PBS containing 10 % FBS for 1 hour at RT. Intestinal lavage was prepared by vortexing the 
intestinal content collected in 3 ml of PBS during 3 minutes. Samples were centrifuged at 
8,000xg for 2 minutes and removed the supernatant for assaying. Intestinal content supernatants 
or mice serum (to IgG analysis) were applied to the wells after the blocking step and incubated 
at 4ºC O/N. The antibody used for detection was goat anti mouse IgA HRP (Southern Biotech) 
or goat anti mouse IgG-heavy and light chain HRP (Bethyl) together with Sure Blue TMB 1-
Component Microwell Peroxidase Substrate and TMB Stop Solution (Biogen). The absorbance 
was read at 450 nm. 
 
3.18 Adoptive transfer experiments 
CD4+ T cells were purified from pooled spleens and lymph nodes of OT-II CD4+ TCR 
transgenic mice or B6/SJL mice expressing CD45.1 by negative selection (Miltenyi Biotec) 
using a cocktail of biotin-conjugated antibodies (anti-CD11c, CD11b, B220, MHC-II, CD8, 
GR1, CD16/32 (BD Bioscience) and anti-CD25, CD44 (Biolegend) followed by separation with 
Streptavidin-microbeads (Miltenyi Biotec). Purified CD4+ T cells from OT-II were incubated at 
5×106 cells/ml in PBS with 0.5 µM CellTrace™ Violet (Invitrogen) for 10 minutes at 37Cº. The 
reaction was stopped with 5% FBS PBS. CD4+ OT-II T cells (2–5×105) were  transferred just 
after challenge in the ear dermis either with 5x104 metacyclic promastigotes of Leishmania-
OVA, rVACV-OVA (kindly provided by J. Yewdell, NIAID, Bethesda) or dead Leishmania 
OVA (1x105). Four days after adoptive transfer, the dLNs were removed to perform antigen 
presentation in vitro.  
CD4+ CD45.1 T cells (6×106) were adoptively transferred into recipient mice. IL-17 and IL-22 
intracellular production by flow cytometry in PPs T cells was determined 14 days after transfer 
by PMA and Ionomycin re-stimulation and intracellular cytokine staining followed by flow 
cytometry. 
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3.19 Antibiotic Treatment, SFB quantification and colonization with Lactobacillus 
plantarum 
For ablation of intestinal bacteria, an antibiotic cocktail of 1 g/L each of Ampicillin (Normon), 
Neomycin sulfate (Sigma Aldrich), Metronidazole (Sanofi), 0.5 g/L Vancomycin (Pfizer) and 
Sucralose (Sigma Aldrich) 4 mg/ml was used as previously described (Rakoff-Nahoum et al., 
2004). For selective depletion, Vancomycin alone was also used as previously described 
(Ivanov et al., 2008). Antibiotics were added into the drinking water on a weekly basis. For 
treatment from birth, breeding pairs were kept with the antibiotic cocktail. Control cages were 
kept on regular water plus sucralose. SFB in feces was detected by PCR (IDEXX Bioresearch) 
or by qPCR in feces , briefly microbial DNA was isolated from mouse fecal samples using 
QIAamp PowerFecal Pro DNA kit (Qiagen), according to manufacturer's instructions. SFB 
DNA was then detected by quantitative PCR with SFB specific primers (See Table 3.2 for 
primers sequence) and SYBR-Green PCR master mix. SFB quantification was performed with 
reference to a standard curve generated with quantified plasmid DNA where SFB 16S rRNA 
gene has been cloned in PCR-blunt II vector (ThermoFisher) according to suppliers' 
instructions.    
Mice treated with antibiotics in utero until the weaning, were inoculated by gavage with L. 
plantarum. One hour prior to the bacterial gavage mice were injected intraperitoneally with 3 
mg of cimetidine HCl (Sigma Aldrich) and 0.02 mg of sincalide (Tebu-bio) in 100 µl of PBS to 
inhibit stomach acid secretion and empty the gallbladder to improve the colonization as 
previously described (Iida et al., 2013). For preparation of bacterial inocula, L. plantarum was 
grown O/N on MRS Broth medium (Oxoid) at 37°C in aerobic conditions. The bacteria were 
suspended in PBS. Mice were gavaged with 200 μl of inoculum (dose 1x106). Mice received 
doses every two days during the four weeks.  
 
3.20 Analysis of bacterial translocation 
Liver was aseptically removed and homogenized in sterile-filtered 0.05% NP40 1% BSA PBS 
before plating serial dilutions on LB agar plates, which were then incubated at 37ºC in aerobic 
conditions without light. 
 
3.21 Bacterial DNA isolation and 16S gene sequencing 
Ultra-Deep Microbiome Prep10 (Hain Lifescience) was used accordingly to manufacturer´s 
instructions to isolate enriched microbial DNA from fresh liver and to remove of animal host 
DNA. Microbial genomic DNA from bound Control-hFc, Mincle-hFc or not bound Mincle-hFc 
fractions or Mincle deficient mice and their WT littermates intestinal content was isolated by 
using QIAamp DNA Mini Kit or QIAamp DNA Stool Mini Kit (Qiagen) respectively. PCR and 
sequencing were performed following the 16S Metagenomic Sequencing Library Preparation 
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guide (Illumina Inc.) The V3-V4 region of 16S rDNA was amplified using the primers 
recommended in this guide (See Table 3.2 for primers sequence). One PCR reaction was 
performed per sample and one single amplicon of approximately 460 bp was created. 2x Kappa 
HiFi Hot Start Ready Mix (Kappa Biosystems, Boston, MA) was used for the first amplification 
step. AMPure XP beads (Beckman Coulter, Brea CA) were used to purify the amplicons and to 
remove free primers and dimer species. Each amplicon (5 µl) were used as template in a second 
Index PCR. This second PCR attached dual indices and Illumina sequencing adapters to each 
amplicon using the Nextera XT index Kit (Illumina San Diego, CA). An additional clean-up 
step was performed with the AMPure XP beads. All the libraries were run in a Bioanalyzer 
DNA 1000 chip (Agilent Tecnologies Waldbronn, Germany) to verify the size of the product. 
Libraries were quantified by fluorometric method (Qubit dsDNA) and quality was check in the 
2100 Agilent Bioanalyzer. All libraries were dilute to the same concentration, using Illumina 
Resuspension Buffer (RSB) and were combine an equal volume of all of them in the same pool 
to sequence. The sample pool (10 nM) was denatured with 0.2 N NaOH, then diluted to 6 pM 
and combined with 50% (v/v) denatured 6 pM PhiX, prepared following Illumina guidelines. 
Samples were sequenced on the MiSeq sequencing platform, using a 2 x 300 cycle V3 kit, 
following standard Illumina sequencing protocols. 
 
3.22 Processing of 16S sequencing data 
Samples were analysed using BaseSpace Application 16S Metagenomics v1.0 (Illumina) to 
determine the bacterial taxonomical composition. This program use Illumina-curated version of 
the GreenGenes taxonomic database and RDP Classifier (Ribosomal Database Project). For 
some additional data analysis, the “Quantitative Insights into Microbial Ecology” software 
(QIIME version 1.9.0) was used. Processed reads were then clustered in Operational taxonomic 
units (OTUs) using UCLUST with a similarity threshold of 0.97 and were aligned using PyNast 
against 16S reference database GreenGenes version 13.8 using default parameters. Enrichment 
index was obtained by comparing the relative abundance of each genus in Mincle-hFc-enriched 
and depleted fractions. Specificity index was calculated by comparing the relative abundance of 
each genus in Mincle-hFc and Control-hFc enriched fractions. 
 
3.23 Serum hepatic parameters and metabolomics profiling 
Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), total and indirect bilirubin 
were measured by using an automatic biochemical analyser (Dimension RxL Max Integrated 
Chemistry System, Siemens). For metabolomics profiling, liver was collected after perfusion 
through the heart with cold PBS. An aliquot of approx. 20 mg was immediately freeze-clamped 
in liquid nitrogen and stored at −80 °C until lipid extraction and analysis. Liver tissue was lysed 
in cold MeOH:H2O (1:1, sample:solvent 1:10 ratio) with a TissueLyser LT homogenizer 
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(Qiagen). Afterwards, liver homogenate was split in two aliquots for the metabolomic profiling 
of diacylglycerides (DAG) and free fatty acids (FFA) using HPLC-ESI-MS-QTOF and GC-EI-
MS-QTOF (Agilent Technologies, Germany) as previously reported (Gonzalez-Pena et al., 
2017). For DAG profiling, the resulting data matrix is composed of all individual species of 
DAGs detected in the samples sorted by their characteristic retention time and neutral mass, and 
the abundance of each compound for each sample. DAGs were identified by the exact mass and 
by the elucidation of MS/MS spectra obtained using a LC-MS/MS analysis in product ion mode. 
In contrast, for FFA profiling, the resulting matrix is made of all individual species of FFAs 
detected in the samples sorted by their characteristic retention time and target ion, and the 
abundance of each compound for each sample. FFAs were identified by comparing their 
retention time, retention index and mass fragmentation patterns with those available in an in-
house library as described (Mastrangelo et al., 2015). 
 
3.24 Statistics 
Statistical significance was determined by parametric Student´s t-test, by Mann & Whitney´s U 
test or one-way ANOVA and Bonferroni post-hoc test using GraphPad Prism (GraphPad 
Software) with *, p < 0.05; **, p < 0.01; ***, p < 0.001.  
 
 
 
 
Antibody (anti-) Fluorophore Vendor
 CD45 biotin, FITC, PE, PerCP-Cy5.5, V450, APC eBioscience
 CD45 APC-Cy7 Tonbo Biosciences
 rat IgG1, κ (isotype) biotin Biolegend
BST2 APC Biolegend
CCR7  PE, APC eBioscience
CD103 biotin, FITC, PE, PerCP-Cy5.5, V450, APC eBioscience
CD103 BUV395 BD Biosciences
CD115 biotin Thermo Fisher Scientific
CD11b biotin, FITC, PE, PerCP-Cy5.5, V450, APC eBioscience
CD11b FITC BD Biosciences
CD11b BV605,APC-Cy7 Biolegend
CD11b APC-Cy7 Biolegend
CD11c biotin, FITC, PE, PerCP-Cy5.5, V450, APC eBioscience
CD11c BUV395 BD Biosciences
CD11c Alexa700 Biolegend
CD172 (SIRP1α) biotin, FITC eBioscience
CD172 (SIRP1α) PerCP-Cy5.5 Biolegend
CD185 (CXCR5) PE, APC Biolegend
CD19 biotin, FITC, PE, PerCP-Cy5.5, V450, APC-Cy7 eBioscience
CD196 (CCR6) PE Biolegend
CD3 biotin, FITC, PE, PerCP-Cy5.5, V450, APC eBioscience
CD4 biotin, FITC, PE, PerCP-Cy5.5, V450, APC eBioscience
CD4  PE-Cy7 Biolegend
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Table 3.1 Antibodies used in this study. From the left to the right: Antigen, fluorophore and 
vendor. 
 
Table 3.2 Primers used in this study. From the left to the right: Gene name, forward and 
reverse sequences (5´-3´). 
 
Antibody (anti-) Fluorophore Vendor
CD40 APC BD Biosciences
CD44 biotin, FITC, PE eBioscience
CD45 BV510 Biolegend
CD45.1 biotin, FITC, PE, PerCP-Cy5.5, V450, APC ,PE-Cy7eBioscience
CD45-R (B220) BV421 BD Biosciences
CD62L biotin, PE eBioscience
CD64  PE-Cy7 Biolegend
CD86 PE Tonbo Biosciences
CD8α biotin, FITC, PE, PerCP-Cy5.5, V450, APC eBioscience
CD90.2 (Thy-1.2) APC Biolegend
F4/80 FITC Biolegend
Gr-1 biotin, FITC, PE, APC eBioscience
HLA-DR BV570 Biolegend
human IgG (Fc gamma) biotin, PE eBioscience
I-A
b
 (MHC-II) biotin, FITC, APC eBioscience
I-A
b
 (MHC-II) AF700 Biolegend
IFN-γ APC BD Biosciences
IgA  biotin eBioscience
IgA PE Thermo Fisher Scientific
IgG PerCP-Cy5.5 Biolegend
IL-17A APC-Cy7, PE BD Biosciences
IL-17A Brilliant Violet 605™ Biolegend
IL-22 PE ,PerCP-Cy5.5 Biolegend
Ly6C biotin, FITC, PE, PerCP-Cy5.5, V450, APC eBioscience
Ly6G PE BD Biosciences
Ly6G BV510 Biolegend
MERTK (Mer) PE Biolegend
Mincle (1B6) - Medical& Biological Labs
PD-1 biotin ,BV421 Biolegend
Siglec-F BV421 BD Biosciences
Streptavidin PE, PerCP-Cy5.5 ,APC eBioscience
Streptavidin BV786 BD Biosciences
Gene name Forward (5´-3´) Reverse (5´-3´)
mDectin-1 CTLD TTTCCCGAATTCTCTTGCCTTCCTAATTGGAT TTTCCCGCGGCCGCAGTTCCTTCTCACAGATAC
Gadph TGAAGCAGGCATCTGAGGG CAGGAAGTAGGTGAGGGCTTG
Clec4e AGTGCTCTCCTGGACGATAG CCTGATGCCTCACTGTAGCAG
Tgfb GCATGGCTGAACCAAGGA AAAGAGCAGTGAGCGCTGAATC
Il6 CCGTGTGGTTACATCTACCCT CGTGGTTCTGTTGATGACAGT
Il23a TGCTGGATTGCAGAGCAGTAA GCATGCAGAGATTCCGAGAGA
Il12b GGAAGCACGGCAGCAGAATA AACTTGAGGGAGAAGTAGGAATGG
Reg3g TCCACCTCTGTTGGGTTCAT AAGCTTCCTTCCTGTCCTCC
Saa1 CATTTGTTCACGAGGCTTTCC GTTTTTCCAGTTAGCTTCCTTCATGT
bactin GGCTGTATTCCCCTCCATCG CCAGTTGGTAACAATGCCATGT
Acc GATGAACCATCTCCGTTGGC GACCCAATTATGAATCGGG
Ppara ACAAGGCCTCAGGGTACCA GCCGAAAGAAGCCCTTACA
Fas GCGGGTTCGTGAAACTGATAA GCAAAATGGGCCTCCTTGATA
Scd1 TTCTTGCGATACACTCTGGTGC CGGGATTGAATGTTCTTGTCGT
Srebpc GGCACTGAAGCAAAGCTGA TCATGCCCTCCATAGACACA
Pepck CCATCACCTCCTGGAAGAACA ACCCTCAATGGGTACTCCTTCTG
Cpt1a CTCCGCCTGAGCCATGAAG CACCAGTGATGATGCCATTCT
G6pase CGACTCGCTATCTCCAAGTGA GTTGAACCAGTCTCCGACCA
SFB TGT GGG TTG TGA ATA ACA AT GCG AGC TTC CCT CAT TAC AAG G
16SrRNA TCGTCGGCAGCGTCAGA TGTG GTCTCGTGGGCTCGGAGATGTGTA
TATAAGAGACAGCCTACGGGNGGCWGCAG TAAGAGACAGGACTACHVGGGTATCTAATCC
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4. RESULTS  
4.1.1 Analysis of Mincle contribution to the immunity against Leishmania major. 
C-type lectin receptors (CLRs) are versatile receptors sensing self and non-self ligands (Iborra 
and Sancho, 2015). CLR-recognition of eukaryote parasites, such as Leishmania, together with 
its recognition by others PRRs, triggers a combination of activating and inhibitory pathways 
that can affect the final host response against the parasite (Lefevre et al., 2013, Woelbing et al., 
2006, Vazquez-Mendoza et al., 2013). For example, the CLR SIGNR3 (mouse Cd209d) is 
targeted by Leishmania infantum in macrophages to inhibit the heterologous CLR Dectin-
1(CLEC7A)-mediated IL-1β secretion, favouring parasite survival (Lefevre et al., 2013). 
Leishmania genus are the causative agents of leishmaniosis, a group of neglected diseases 
whose clinical manifestations vary depending on the infectious Leishmania species but also on 
host factors. The life cycle of the parasite includes two developmental stages, promastigotes and 
amastigotes, which are well adapted to survive in the sand fly insect vector and the mammalian 
host respectively. The extracellular flagellated metacyclic promastigotes develop within the 
sand fly midgut and initiate infection after being inoculated in the skin by the bite of an infected 
fly. The non-motile intracellular forms, amastigotes replicate and maintain infection in the 
vertebrate host. In the mammalian host, Leishmania amastigotes reside mainly in long-lived 
resident macrophages (Sacks and Melby, 2001). The recognition of the parasite by host myeloid 
cells is key to trigger an effective Leishmania protective immunity (Rossi and Fasel, 2018). 
Clearance of Leishmania parasites requires IFN-γ-producing effector cells, mainly CD4+ Th1 
cells, although other cells, such as NK cells (Bajenoff et al., 2006) and CD8+T cells (Belkaid et 
al., 2002) can contribute to this process.  IFN-γ signalling in infected macrophages promotes 
expression of inducible NO synthase (iNOS) and NO production that, together with reactive 
oxygen species (ROS) are essential to kill intracellular parasites (Green et al., 1990). Besides 
IFN-γ, other inflammatory cytokines, such as TNF, can activate the infected macrophages in an 
autocrine manner to produce NO (Bogdan et al., 1990). On the contrary, CD4+ Th2-related 
cytokines, such as IL-4, IL-13, IL-10, and antibody production are associated with alternative 
activated macrophages (Gordon, 2003), which favours parasite survival inside the macrophages 
(Kropf et al., 2005), and a non-healing phenotype (Scott et al., 1988 , Heinzel et al., 1989 , 
Chatelain et al., 1992, Sacks and Noben-Trauth, 2002). The priming and development of an 
effector Th1 adaptive immunity require IL-12 production by specific subtypes of DCs. The 
main source of IL-12 upon Leishmania infection are DCs derived from inflammatory 
monocytes (moDCs) and the migratory CD103+ DCs (Leon et al., 2007, Martinez-Lopez et al., 
2015).  
However, the parasite, in order to escape, target DC activation either being silent or even 
inhibiting DC activation, motility and migration to draining lymph nodes (dLNs) (Ponte-Sucre 
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et al., 2001, Jebbari et al., 2002, Revest et al., 2008, Figueiredo et al., 2012, Hermida et al., 
2014, von Stebut, 2017). The outcome of this interaction, vary depending on the different DC 
subset involved, as they are equipped with different PRRs. In addition, several Leishmania 
species have different PAMPs and/or immune evasion strategies. In particular, low dose 
infection with Leishmania major in mice, which causes a disease that resembles human 
cutaneous leishmaniosis (Belkaid et al., 2000), is a poor inducer of DC activation, inhibiting 
migration of  DCs to dLNs (Ng et al., 2008, Ribeiro-Gomes et al., 2012). DCs do eventually 
migrate and promote Th1 protective immunity and macrophage microbicide activity (Leon et 
al., 2007). The mechanisms by which Leishmania initially blunts DC activation and T cell 
priming remain ill-defined. It has been argued that they may involve uptake of apoptotic-
infected neutrophils by DCs (Ribeiro-Gomes et al., 2012, Ribeiro-Gomes et al., 2015, Peters et 
al., 2014) or direct DCs contact with parasite products (Srivastav et al., 2012). However, the 
role of myeloid-CLRs, mediating L. major-induced DCs suppression is unknown. Here, we aim 
to analyse the role of Mincle to this process (Fig. 4.1.1). As a dual CLR, Mincle can recognize 
self-ligands released by dead cells and non-self ligands on the cell walls of bacteria and fungi, 
triggering phosphorylation of ITAM tyrosine residues in the FcRγ chain by Src-family kinases, 
followed by the recruitment and activation of the kinase Syk, that boosts immunity to infections 
and inflammation (Lu et al., 2018). Classically considered an activating CLR, Mincle has 
recently been associated with dampening of immunity (Seifert et al., 2016, Wevers et al., 2014, 
Wuthrich et al., 2015) by repressing IL12-p35 transcription through a Syk-PKB-dependent 
pathway in response to Fonsecaea (Wevers et al., 2014). Uncovering the contribution of Mincle 
to L. major-induced DC suppression will help to improve a rational design of vaccines aimed to 
counteract parasite virulence factors, along with the use of the most adequate adjuvants. 
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Figure 4.1.1 Contribution of the CLR Mincle to L. major-induced immune response. 
Picture displaying the five specific objectives: (1- 3) Addressing L.major-Mincle interaction and 
how it could influence DCs function. (4 and 5) Analysing the effect of Mincle-L.major 
interaction on adaptive immune response and macrophage microbicide response. Mincle, 
macrophage inducible C-type lectin; NO, nitric oxide; ROS, reactive oxygen species 
 
4.1.2 Leishmania releases a soluble proteinaceous ligand for Mincle 
While screening for pathogens expressing Mincle ligands by dot blot, we found that the human 
Mincle ectodomain-hFc chimera (Mincle-hFc) specifically bound soluble Leishmania major (L. 
major) extracts from freeze-thawed promastigotes (Fig. 4.1.2 A, left). Mincle-hFc also bound to 
blotted supernatants from L. major promastigotes kept for 3 hours at 37ºC to favour secretion 
(Fig. 4.1.2 A, right) and detected plated soluble Leishmania antigen (SLA) or supernatants 
(SN) by ELISA (Fig. 4.1.2 B); in contrast, control-hFc or macrophage C-type lectin (MCL)-hFc 
did not bind to plated Leishmania extracts (Fig. 4.1.2 C). Loss of binding upon boiling of the 
parasite preparations indicated that the ligand is heat-sensitive (Fig. 4.1.2 A, B). Treatment of 
plated Leishmania extract with sodium periodate, which oxidizes glycans, did not affect binding 
of Mincle-hFc to the Leishmania extract, but did inhibit the trehalose-dependent binding to 
TDM (Fig. 4.1.2 D).  
To determine whether the ligand bound cellular Mincle, B3Z NFAT reporter cells (Karttunen et 
al., 1992) were transduced with a chimera comprising the extracellular human Mincle and 
intracellular CD3ζ, or alternatively with the wild type (WT) mouse Mincle receptor co-
transduced with the FcRγ chain and Syk. The CD3ζ chimera responds to any multimeric ligand, 
whereas WT Mincle requires the Syk kinase transduction pathway to activate an NFAT reporter 
(Sancho et al., 2009). Plated Leishmania lysates triggered the Mincle-CD3ζ reporter, but not the 
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WT Mincle-FcRγ-Syk or the parental cell line (Fig. 4.1.2 E). SLA did not trigger the Mincle-
CD3ζ chimera or the WT Mincle (not shown), suggesting a low valency of the soluble ligand. In 
contrast, SLA blocked the triggering of WT Mincle or CD3ζ chimera by plated TDB in a dose-
dependent and heat-sensitive manner (Fig. 4.1.2 F). In addition, fluorochrome-labeled SLA 
bound to Mincle-expressing B3Z cells, but not to the parental cell line (Fig. 4.1.2 G). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.2. Leishmania releases a soluble ligand for Mincle. (A) Dot blots for Mincle-hFc 
(top) or control-hFc (bottom) with membranes spotted with fresh or boiled soluble Leishmania 
extracts (SLA) (left) or supernatants (SN) (right) from the indicated dilutions of stationary 
cultured parasites. Culture medium (none) or TDM were used as controls.  (B) ELISA with 
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Mincle-hFc of different doses of SLA or supernatants (fresh or boiled) from L. major 
promastigotes and controls (none or TDB). (C) Leishmania extract (SLA) was plated and 
detected by ELISA using Mincle-, MCL- or Control-hFc. Plated 1B6 was used as a positive 
control for ELISA. (D) Plated Leishmania extract (SLA) and TDM were treated with sodium 
periodate and detected by  ELISA using Mincle-hFc or Control-hFc.(E ) NFAT reporter activity 
in response to 106, 105 or 104 of plated lysed-Leishmania or TDB in B3Z cells expressing 
human Mincle-CD3 chimera, WT mouse Mincle receptor co-expressing Syk and FcR, or the 
parental cells. (F) NFAT reporter activity in B3Z cells expressing WT mouse Mincle receptor, 
FcR, and Syk and exposed to plated TDB in the presence of the indicated dilutions of fresh or 
boiled SLA. (G) Staining with anti-Mincle (left) and fluorochrome-labeled SLA on control and 
Mincle-expressing B3Z cells. (A, C, D, G) Data are from one representative experiment of four 
(A) or three (C, D, G) performed. (B, E, F) Bars show arithmetic mean + SEM corresponding to 
three independent experiments. * p < 0.05; ** p < 0.01; *** p < 0.001 (one way ANOVA with 
Bonferroni post-hoc test). 
 
Mincle-hFc also stained fixed and permeabilized L. major promastigotes, whereas Dectin-1-hFc 
did not (Fig. 4.1.3 A). Binding of Mincle-hFc to fixed and permeabilized L. major was 
specifically inhibited by preincubation of the ectodomain with 2F2 anti-Mincle or with soluble 
TDM (Fig. 4.1.3 B). Moreover, treatment of fixed and permeabilized Leishmania promastigotes 
with proteinase K, trypsin, heat, or low pH, but not DNaseI, inhibited labeling by Mincle-hFc 
chimera, suggesting a proteinaceous nature of the ligand (Fig. 4.1.3 C). Notably, other 
Leishmania species were also specifically stained by Mincle-Fc (Fig. 4.1.3 D). Confocal 
analysis of Mincle-hFc staining in fixed and permeabilized L. major promastigotes revealed an 
intracellular granular pattern, including the flagellar pocket close to the kinetoplast, a unique 
site for exocytosis (Fig. 4.1.3 E). Mincle-Fc also stained the parasitophorous vacuole containing 
L. major amastigotes after uptake of the parasite by cultured M-CSF bone marrow-derived 
macrophages (Fig. 4.1.3 F) alongside the staining of the endogenous nuclear ligand for Mincle 
(Yamasaki et al., 2008). Dectin-1 Fc did not stain fixed and permeabilized promastigotes or 
amastigotes (Fig. 4.1.3 E, F). Thus, Leishmania produced a soluble proteinaceous ligand(s) for 
Mincle that was detected in all tested Leishmania species and was present at both the 
promastigote and amastigote stages. 
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Figure 4.1.3. The Leishmania ligand for Mincle is proteinaceous and present at all parasite 
stages. (A) Mincle-hFc and Dectin-1-hFc staining with Hoechst 33258 counterstaining in live L. 
major promastigotes or paraformaldehyde (PFA)-fixed parasites permeabilized with NP-40. (B) 
Mean fluorescence intensity in fixed and permeabilized L. major promastigotes stained with 
Dectin-1-hFc (Control-hFc) or Mincle-hFc preincubated with titrated dilutions of anti-Mincle 
(clone 2F2), isotype control antibody (mouse IgM), or TDM (10 µg/ml starting dose, 3 fold 
dilution). Bars show arithmetic mean + SEM corresponding to three independent experiments. * 
p < 0.05; ** p < 0.01; *** p < 0.001 (one-way ANOVA with Bonferroni post-hoc test). (C) 
Fixed and permeabilized L. major promastigotes were subjected to the indicated treatments 
(colors) or untreated (black) and stained with Mincle-hFc chimera. Gray histograms show 
Dectin-1-hFc staining. (D) Dectin-1-hFc or Mincle-hFc and Hoechst 33258 staining of  live or 
fixed and permeabilized (PFA + NP40) promastigotes of different Leishmania species (E, F) 
Confocal images of Mincle-hFc  and Dectin-1-hFc staining in fixed and permeabilized 
Leishmania promastigotes (E) and MCSF bone-marrow-derived macrophages preincubated with 
promastigotes (F). Nuclei are counterstained with DAPI. Scale bar: 5 μm. (A, C-F) Plots and 
images are from single representative experiments of three performed.  
4.1.3 Mincle is expressed during Leishmania infection 
The typical route of Leishmania infection is a skin bite by a parasite-inoculated sandfly. We 
therefore analysed Mincle expression in dermal cell types of WT and Mincle-deficient (Clec4e-/-
) mice after L. major infection. The pinnae of both ears were inoculated by intradermal (i.d.) 
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injection of 1000 L. major metacyclic promastigotes, and ear infiltrates were analyzed 24 hours 
later and compared with dermis taken from the ears of uninfected mice. Mincle expression by 
myeloid cells was modest in unchallenged dermis (Fig. 4.1.4 A), but was upregulated upon L. 
major infection in tissue macrophages, neutrophils, and monocyte-derived DCs (MoDCs) 
infiltrating the infection site (Fig. 4.1.4 A, B), and was maintained throughout the course of 
infection (Fig. 4.1.4 B). Mincle staining of myeloid cells was also observed in human skin 
samples and serial spleen sections from patients infected with Leishmania infantum (Fig. 4.1.4 
C, D). 
Figure 4.1.4 Mincle is expressed during Leishmania infection. (A and B) Expression of 
Mincle on the indicated cell subsets from the ear of naive or L. major-infected WT or Clec4e-/- 
mice 1 day postinfection (p.i) (A) or on monocyte-derived DC (MoDC) at the indicated time 
points after infection (B).(A and B) Histograms depict representative data from three 
independent experiments (n=9). (C) Immunofluorescence of human skin infected with L. 
infantum and labeled with anti-HLA-DR and anti-human Mincle (1B6). (D) Spleen samples 
from L. infantum-infected individuals immunostained with antibodies to human Mincle (2A8), 
CD68, and CD23. (C, D) Single representative stainings are shown of three performed. 
 
4.1.4 Mincle deficiency increases resistance to cutaneous leishmaniasis 
To determine the contribution of Mincle to the immune response against L. major, we 
monitored cutaneous disease during an 11-week period after ear inoculation with 1000 L. major 
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metacyclic promastigotes in WT or Clec4e-/- mice. In the first 2 weeks after infection, the 
inflammatory pathology in Clec4e-/- mice was similar to or greater than that in WT mice, but the 
response subsequently plateaued and there was no development of dermal lesions (Fig. 4.1.5 A). 
Therefore the third week of infection, parasite loads in the ears and dLNs of Clec4e-/- mice were 
90% lower than those of their WT counterparts (Fig. 4.1.5 B, C). Real-time tracking of i.d. ear 
infection with L. major mCherry confirmed better control of infection in Clec4e-/- mice, with 
significantly lower parasite load at all times analyzed (Fig. 4.1.5 D). Mincle-deficient mice thus 
controlled the infection earlier and more effectively than WT mice, leading to reduced 
pathology. 
 
Figure 4.1.5. Mincle deficiency increases resistance to cutaneous leishmaniasis. (A) Time 
profiles of lesion diameter in the ear pinnae of WT and Clec4e-/- mice infected i.d. with 1000 L. 
major parasites. Data arithmetic means  SEM from a representative experiment (n=16) of three 
performed. (B, C) Parasite load in the ear (B) and dLNs (C) of WT and Clec4e-/- mice at the 
indicated times after i.d. infection in the ear with 5 x 104 L. major parasites. Squares show 
individual data and horizontal bars show arithmetic means from a representative experiment of 
three performed. (D) Left: In vivo imaging of mouse ears at the indicated times after i.d. 
inoculation with 5 x 104 mCherry+ L. major metacyclic promastigotes. Right: Progression of 
fluorescence signal (pixel/second/cm2/sr) expressed as arithmetic mean  SEM (n=6). (A-D) * p 
< 0.05; ** p < 0.01; *** p < 0.001 (Student’s t test at each time point). 
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4.1.5 Mincle deficiency strengthens the adaptive response to L. major 
Polyclonal effector CD4+ T cells producing IFN-, but not CD8+ T cells, were significantly 
more abundant in the ears of infected Clec4e-/- mice at 3, 6 and 10 weeks p.i. (Fig. 4.1.6 A, B). 
CD4+ T cells present in dLNs from infected Clec4e-/- mice showed augmented production of 
IFN-, but not IL-10, in response to SLA (Fig. 4.1.6 C). To investigate the mechanism of the 
enhanced adaptive response to L. major in the absence of Mincle, we analyzed early CD4+ T 
cell priming. As described (Ribeiro-Gomes et al., 2012, Pagán et al., 2013)infection with L. 
major expressing the model antigen ovalbumin (OVA) induced poor priming of OVA-specific 
CD4+ T cells (Fig. 4.1.6 D). Priming was boosted in Clec4e-/- mice, with enhanced CD4+ T cell 
proliferation in vivo and IFN- production upon OVA restimulation ex vivo (Fig. 4.1.6 D, E). 
The specificity of the Mincle-dependent decrease in CD4+ T cell priming for L. major was 
confirmed by identical effector responses in WT and Clec4e-/- mice upon infection with OVA-
expressing vaccinia virus (Fig. 4.1.6 D, E). These data show that Leishmania targets Mincle to 
decrease priming of a CD4+ Th1 cell-type response against the parasite. 
To determine the relevance of enhanced priming in a context of vaccination, we transferred 
OVA-specific CD4+ T cells intravenously (i.v) and subsequently injected 1 x 105 freeze-thawed 
L. major-OVA i.d. into the ear. Injection of dead parasites into Clec4e-/- mice resulted in 
increased numbers of OVA-specific CD4+ T cells producing IFN- upon restimulation ex vivo 
(Fig. 4.1.6 F). We next analyzed whether Mincle deficiency also strengthens the function of the 
memory CD4+ T cell compartment. Vaccination with freeze-thawed Leishmania followed by L. 
major rechallenge 4 weeks later induced IFN-+ CD4+ effector T cells in the ear of Clec4e-/- but 
not WT mice (Fig. 4.1.6 G), thus generating a protective response with reduced parasitemia 
(Fig. 4.1.6 H). This Mincle-dependent vaccination deficiency using freeze-thawed Leishmania 
extracts in WT mice could be reverted by the use of CpG as adjuvant (Fig. 4.1.6 G, H), 
consistent with published findings (Walker et al., 1999). These results indicated that upon 
sensing Leishmania, Mincle inhibited the generation of effector and memory CD4+ T cells and 
impaired the adaptive response to L. major.  
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Figure 4.1.6 Increased adaptive response and enhanced CD4+ T cell priming during L. 
major infection in Mincle-deficient mice. (A-C) WT and Clec4e-/- mice were infected i.d. in 
the ear with 5 x 104 L. major parasites. (A) IFN- production in CD4+ T cells in response to 
polyclonal restimulation of ear infiltrates at the indicated times. Upper part: representative plots 
3 weeks p.i. Bottom part: individual data and arithmetic means (B) Frequency of IFN-γ+ in 
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CD8+ T cells in the ear stimulated as in (A).(C)  IFN- (right) or IL-10 (left) in supernatants 
from dLN cells extracted at the indicated times and restimulated with SLA. Data are arithmetic 
means + SEM (n=6) of one representative experiment of three performed. (D-E) WT and 
Clec4e-/- mice were transferred with CD45.1+ OTII OVA-specific T cells labeled with Cell 
Violet and infected i.d. in the ear with 5 x 104 particles of either L. major, L. major expressing 
OVA (L. major-OVA), or recombinant vaccinia virus expressing OVA (VACV-OVA). (D) 
Representative histograms showing Cell Violet dilution in OTII cells in dLNs, 4 days p.i. (E) 
Representative plots of Cell Violet dilution and IFN- production following ex vivo 
restimulation with OVA peptide.  Bottom: quantification of IFN-+ OT-II absolute numbers in 
the dLNs. (F) Mice were vaccinated in the ear with 1x105 F-T parasites and transferred with 
OTII as in (D). Quantification of OTII cells that were IFN-+ in the dLNs upon ex vivo 
restimulation with OVA peptide. (G-H) WT and Clec4e-/- mice were vaccinated i.d. in the ear 
with F-T L. major and challenged with live parasites in the same site 4 weeks later. (G) IFN- 
production in CD4+ effector T cells in the ear upon restimulation as in (A), assessed 2 weeks p.i. 
(H) Parasite load in the infected ears was evaluated 4 weeks p.i.. (A-C, E–G) Individual data 
and arithmetic mean of a representative experiment of three performed. *p < 0.05; **p < 0.01; 
***p < 0.001: (A–F) Student’s t test; (G.H) one way ANOVA with Bonferroni post hoc test. 
4.1.6 Mincle absence increases DCs activation and migration to dLNs after L. major 
infection 
Given the increased adaptive response, we next investigated whether Mincle-deficient DCs had 
an enhanced ability to prime anti-L. major responses. DCs extracted from draining lymph nodes 
(dLNs) of Clec4e-/- mice were better than WT at restimulating L. major-specific CD4+ T cells 
obtained from healed WT mice (Fig. 4.1.7 A). MoDCs infiltrating the dermis of Mincle-
deficient mice also showed upregulation of the activation markers CD40 and CD86 and the 
chemokine receptor CCR7 at 20h and 14d after infection (Fig. 4.1.7 B). In addition, L. major 
infection decreased the numbers of migratory DCs in a Mincle-dependent manner (Fig. 4.1.7 
C). The effect of Mincle on the capacity of dermal DCs to migrate to the dLNs was further 
investigated in FITC skin sensitization assays. L. major infection inhibited migration of FITC+ 
CD11c+ DCs to dLNs in WT mice but not in Clec4e-/- mice (Fig. 4.1.7 D). These results suggest 
that Leishmania sensing by Mincle impaired DCs activation in the infection site and 
subsequently limited their capacity to migrate to dLNs, contributing to the reduced priming to L. 
major in the presence of Mincle. 
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Figure 4.1.7 Enhanced DCs activation and migration to dLNs after L. major infection in 
Mincle-deficient mice. (A) IFN-γ in supernatants of T cells from healed L. major-infected mice 
after co-culture for 3 d with CD11c+ cells recovered from the dLNs of WT and Clec4e-/- mice 2 
d p.i. Data are arithmetic means + SEM from two independent experiments (n=6). (B) Left 
panels: Representative histograms of CD40, CD86 and CCR7 staining in MoDCs 
(CD11b+Ly6C+CD11c+MHCII+ gated cells) from ears of infected mice. Right panels: Mean 
fluorescence intensity (MFI) of CD40, CD86 and CCR7 expression on MoDCs. (C) 
Representative dot plots (Left) and frequencies (Right) of CD11c- and CD40-positive cells in 
dLNs from uninfected mice or 24 h after L. major infection in the ear. (D) Ears of mice 
inoculated with PBS in the left ear and L. major parasites (105) in the right ear were FITC 
painted and dLNs were harvested 24h later. Left: Representative plots of dLN cells gated for 
CD11c and stained with anti-CD40 and FITC. Right: frequencies of FITC+ CD11c+ dLN cells. 
(B-D) Individual data and arithmetic means corresponding to a representative experiment of two 
(B) or three (C, D) performed. (A-D) * p < 0.05; ** p < 0.01; *** p < 0.001 (Student’s t test). 
4.1.7 L. major promotes a Mincle- and SHP1-dependent inhibitory axis in CD11c+ 
GMCSF-derived cells 
To test whether increased DCs activation in the absence of Mincle was intrinsic, we generated 
GMCSF bone-marrow-derived cells from WT and Clec4e-/- mice. Stimulation with freeze-
thawed L. major induced increased expression of CD40, CD86 and CCR7 in Mincle-deficient 
CD11c+ GMCSF-derived cells (Fig. 4.1.8 A, B) suggesting an intrinsic effect. As Syk is 
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downstream Mincle (Yamasaki et al., 2008), we tested the absence of Syk in the CD11c 
compartment (CD11cCre Sykflox/flox, named CD11cΔSyk mice)(Iborra et al., 2012). GMCSF 
bone-marrow-derived cells from CD11c∆Syk mice showed impaired activation by freeze-
thawed L. major (Fig. 4.1.8 A, B), suggesting the possible existence of an unidentified 
activating Syk-coupled DCs receptor for L. major (Lefevre et al., 2013).  
MCL and Mincle are mutually regulated and act as heterodimers for binding to TDM (Kerscher 
et al., 2016b, Lobato-Pascual et al., 2013, Miyake et al., 2013, Miyake et al., 2015). Consistent 
with these reports, GMCSF bone-marrow-derived cells from Clec4d-/- mice lacked expression of 
not only MCL but also Mincle (Fig. 4.1.8 C), Mincle expression was rescued by transduction 
with WT MCL or MCLWAA (Fig. 4.1.8 C), which contains a mutation in calcium-binding motif 
of the C-type lectin (Miyake et al., 2015). The impaired expression of Mincle and MCL in 
Clec4d-/- mice resulted in increased activation of CD11c+ GMCSF-derived cells exposed to 
freeze-thawed L. major (Fig. 4.1.8 D). Reexpression of Mincle mediated by transduction of 
both MCL and MCLWAA correlated with impaired CD11c+ GMCSF-derived cells activation by 
L. major (Fig. 4.1.8 D), suggesting that regulation of Mincle expression by MCL contributes to 
responses to L. major.  
Infection with Fonsecaea triggers Akt-dependent repression of IL12p35 transcription (Wevers 
et al., 2014). In contrast, freeze-thawed L. major did not induce Akt activation in WT mice (Fig. 
4.1.8 E). We hypothesized that DCs activation by L. major might be antagonized by Mincle 
through the recruitment of SHP1 in an inhibitory ITAM (ITAMi) configuration (Aloulou et al., 
2012, Ben Mkaddem et al., 2014, Hamerman et al., 2009, Pasquier et al., 2005). Consistent with 
this notion, treatment with the SHP1/2 phosphatase inhibitor NSC-87877 increased CD11c+ 
GMCSF-derived cells activation by L. major (Fig. 4.1.8 F), and NSC-87877 did not further 
activate Mincle-deficient DCs in response to the parasite (Fig. 4.1.8 F), suggesting that Mincle 
and phosphatase activity act in the same pathway.  
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Figure 4.1.8 Mincle-MCL counter-regulation contributes to CD11c+ GMCSF-derived cells 
inhibition by L. major.(A) Histogram overlays for CD40, CCR7, and CD86 in CD11c+ GM 
from WT and Clec4e-/- mice left untreated (gray histograms) or treated with freeze-thawed (F-T) 
L. major. Data are representative of three independent experiments (n=6). (B) Fold induction of 
MFI for CD40, CCR7 and CD86  upon F-T L. major treatment of CD11c+ GMCSF-derived 
cells obtained from WT, Clec4e-/-, and CD11cΔSyk mice; (C)Staining with anti-Mincle of MCL-
deficient (Clec4d-/-, left) and Mincle-deficient (Clec4e-/-, right) GMCSF-derived cells transduced 
with lentiviruses expressing empty vector, MCL or MCL-WAA. Representative staining of four 
independent cultures and transductions. (D)  Fold induction of MFI for CD40, and CCR7 upon 
F-T L. major treatment of CD11c+ GMCSF-derived cells obtained from WT and Clec4d-/- 
CD11c+ GMCSF-derived cells transduced with empty vector, MCL, or MCL-WAA. (E) 
Western blots for P-Akt (Thr308) and total Akt in CD11c+ GMCSF-derived cells from WT and 
Mincle-deficient (Clec4e-/-) mice treated or not (none) with F/T L. major or zymosan for the 
indicated times. A representative experiment is shown of two performed. (F) Staining of CD40, 
CD86, and CCR7 on CD11c+ GMCSF-derived cells from WT and Clec4e-/- mice untreated or 
treated with F-T L. major (10:1 ratio to CD11c+cells) in the presence or absence of the SHP1/2 
inhibitor (*i) NSC-87877 at the indicated dose. (B, D, F) Panels show individual data and 
arithmetic mean corresponding to (D) Pooled data from three independent experiments (n = 6) 
or (B, F) one representative experiment of three performed. * p < 0.05; ** p < 0.01; *** p 
<0.001 (B)  One-way ANOVA with Bonferroni post-hoc test (D,F)Student’s t test. 
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Supporting this conclusion, the enhanced freeze-thawed L. major-mediated activation seen in 
Mincle-deficient mice was phenocopied in GMCSF bone-marrow-derived cells from mice 
lacking SHP1 in the CD11c compartment (CD11c∆SHP1) (Abram et al., 2013) (Fig. 4.1.9 A), 
freeze-thawed L. major-induced cytokine production was also higher in GMCSF bone-marrow-
derived cells lacking Mincle or SHP1 (Fig. 4.1.9 B). Moreover, like Clec4e-/- mice tested in 
parallel, CD11c∆SHP1 mice displayed lower ear and LNs parasitemia in response to L. major 
infection (Fig. 4.1.9 C) and showed increased adaptive immunity (Fig. 4.1.9 D). Thus, our 
results suggested that Mincle inhibited CD11c+ GMCSF-derived cells activation through SHP1. 
Figure 4.1.9 Mincle and SHP1 inhibit CD11c+ GMCSF-derived cells activation by freeze-
thawed L. major. (A)  Fold induction of MFI for CD40, CCR7 and CD86 upon F-T L. major 
treatment of CD11c+ GMCSF-derived cells obtained from CD11c+ GMCSF-derived cells from 
WT and CD11cΔSHP1 mice. (B) IL-12p40 and TNF in culture supernatants 20h after 
exposure of WT, Clec4e-/-, and CD11cΔSHP1 CD11c+ GMCSF-derived cells to different doses 
of F-T L. major. Data are arithmetic means + SEM of three independent experiments. (C, D) 
WT, Clec4e-/-, and CD11cΔSHP1 mice inoculated with 5 x 104 L. major parasites i.d. in the ear 
were sacrificed 3 weeks after infection. (C) Parasite load in the infected ear and dLNs. (G) Top: 
intracellular IFN- in CD4+ T cells after polyclonal restimulation of ear infiltrates. Bottom: IFN-
 in supernatants after SLA restimulation of 2 x 106 dLN cells. (A, C, and D) Individual data 
and arithmetic mean corresponding to one representative experiment of three performed. (A–D) 
*p < 0.05; **p < 0.01; ***p < 0.001. (B-D) One-way ANOVA with Bonferroni post-hoc test; 
(A) Student’s t test. 
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4.1.8 L. major shifts Mincle to an inhibitory ITAM configuration that suppresses 
heterologous receptors 
Participation of Mincle and SHP1 in the same axis was further supported by Mincle-dependent 
phosphorylation of SHP1 (but not SHP2) in freeze-thawed L. major-stimulated GMCSF bone-
marrow-derived cells (Fig. 4.1.10 A). Pull-down of SHP1 in WT or FcR-chain-deficient 
GMCSF bone-marrow-derived cells revealed specific FcR-dependent association of SHP1 with 
Mincle (Fig. 4.1.10 B). Moreover, pull-down of Mincle from B3Z transfectants expressing 
tyrosine mutants in the FcR ITAM domain demonstrated that the membrane-distal tyrosine 76 
was crucial for association of Mincle-FcR with SHP1, whereas tyrosine 65 was at least 
partially dispensable (Fig. 4.1.10 C), consistent with the ITAMi configuration (Ben Mkaddem 
et al., 2014).  
We next tested the effect of the L. major-induced Mincle-dependent inhibitory axis on CD11c+ 
GMCSF-derived cells activation promoted by LPS. Freeze-thawed L. major dampened LPS-
induced activation in CD11c+ GMCSF-derived cells and this inhibition was dependent on 
Mincle and Syk (Fig. 4.1.10 D). The ITAMi configuration is dependent on transient activation 
of Syk (Ben Mkaddem et al., 2014). We found that Syk transiently associated with Mincle in 
CD11c+ GMCSF-derived cells stimulated with freeze-thawed L. major in a manner dependent 
on the FcR chain (Fig. 4.1.10 E). Notably, CD11c∆Syk CD11c+ GMCSF-derived cells showed 
impaired SHP1 recruitment to Mincle (Fig. 4.1.10 F). These results suggest that L. major shifts 
Mincle to an ITAMi configuration that suppresses heterologous activating receptors, dampening 
CD11c+ GMCSF-derived cells activation and thus impairing the induction of adaptive immune 
responses.  
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Figure 4.1.10 L. major promotes a Mincle/FcR/SHP1 axis that impairs CD11c+ GMCSF-
derived cells activation. (A) Western blot (WB) for P-SHP1 and total SHP1 in WT and Clec4e-
/- CD11c+ GMCSF-derived cells lysed at the indicated times of stimulation with F-T L. major. 
(B) SHP1 immunoprecipitation and WB for SHP1, FcR and Mincle in WT and Fcer1g-/- 
CD11c+ GMCSF-derived cells lysed at the indicated times of stimulation with F-T L. major. (C) 
Mincle immunoprecipitation in B3Z cells transduced with mouse Mincle (Clec4e), Syk, and 
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either WT FcR chain or the Y76F (left) or Y65F mutants (right). WB for Mincle, FcR and 
SHP1. (D) Fold induction of MFI for CD40 and CD86 upon LPS stimulation (200 ng/ml) of F-T 
L. major-pretreated for 30 min (+) or non-pretreated (-) CD11c+ GMCSF-derived cells from 
WT, Clec4e-/- and CD11cSyk mice. ** p < 0.01; Student’s t test comparing F-T L. major 
pretreatment and no pretreatment within each genotype. (E) Syk (upper blots) and SHP1 (lower 
blots) immunoprecipitation from F-T L. major-treated WT and Fcer1g-/- CD11c+ GMCSF-
derived cells and WB for Syk and Mincle (upper) or SHP1 and Mincle (lower). (F) SHP1 
immunoprecipitation from F-T L. major-treated WT and CD11cSyk CD11c+ GMCSF-derived 
cells and WB for SHP1 and Mincle. (A-F) Western Blots are from single representative 
experiments of at least three performed.  
 
4.2.1 Analysis of the contribution of Mincle to the homeostasis of commensal microbiota in 
the intestine. 
Initially described for pathogen microorganisms, PAMPs are also present in the commensal 
microorganisms that form the microbiota, referred as microbe-associated molecular patterns 
(MAMPs) (Chu and Mazmanian, 2013). Consequently, myeloid PRRs might not only contribute 
to generation of immunity against pathogens, but also could promote host-microbiota symbiosis 
after MAMPs recognition, contributing to tolerance to these commensal microorganisms. 
The CLRs-mediated Syk/CARD9 pathway has been recently identified as protective in the 
context of inflammation-associated cancer through recognition of commensal fungi (Malik et 
al., 2018). In addition, many myeloid CLRs can recognize ligands present in commensal 
microorganisms, SIGNR3 (Cd2009d) and its human homolog DC-SIGN (CD209) can recognize 
several ligands present in different Lactobacillus species (Lightfoot et al., 2015) (Konieczna et 
al., 2015). In addition, SIGNR3 can recognize commensal fungi (Eriksson et al., 2013).  MCL 
(CLEC4D) and DCIR (CLEC4A) bind to intestinal microbiota to a different extent (Hütter et al., 
2014). The best-characterized example is Dectin-1(CLEC7A)-mediated recognition of 
indigenous fungi and control the homeostasis of intestinal immunity by controlling Treg cell 
differentiation through modification of microbiota (Iliev et al., 2012, Tang et al., 2015). Most of 
the knowledge of CLRs recognition of microbiota is based on in vitro or DSS-induced colitis 
studies and how myeloid CLRs-microbiota interaction promotes tolerance to microbiota is still 
poorly described (Smits et al., 2005) (Eriksson et al., 2013). In this particular context, tolerance, 
is not a passive state of unresponsiveness, but implies activation of several mechanisms such as 
the containment of commensals inside the intestine, given that increased microbial translocation 
is associated with systemic inflammation (Sonnenberg et al., 2012). For that, the intestinal 
epithelial cells (IECs), the mucus layer, the generation of antimicrobial peptides and the 
92 
 
synthesis of microbe-specific immunoglobulin A (IgA) in the Peyer’s patches (PPs) constitute 
the “mucosal firewall” (Belkaid and Hand, 2014).  
This mucosal barrier  is regulated by RORγt-dependent cells that include group 3 innate 
lymphoid cells (ILC3) and T helper 17 (Th17) cells, which produce IL-17 and IL-22 and  
modulate antimicrobial peptide secretion by IECs and IgA production in the gut ((Hirota et al., 
2013, Kruglov et al., 2013). Therefore, the absence of RORγt-dependent cells or their mediators 
can lead to a breach of the intestinal barrier, commensal translocation and systemic 
inflammation (Lochner et al., 2011, Sonnenberg et al., 2012). RORγt-dependent cells function 
and/or generation require myeloid-recognition of commensal microbiota, segmented 
filamentous bacteria (SFB) is the prototypical example, and -antigen presentation or -derived 
cytokines such as IL-6 and IL-23 (Ivanov et al., 2006 , Persson et al., 2013, Longman et al., 
2014 , Satpathy et al., 2013). In this regards, many myeloid CLRs, Dectin-1(CLEC7A), Dectin-2 
(CLEC6A in human, Clec4n in the mouse) and Mincle (CLEC4E) mainly drive IL17 production 
by T cells in response to pathogens,  by modulation of myeloid IL-6 and IL-23 secretion 
(Geijtenbeek and Gringhuis, 2016, LeibundGut-Landmann et al., 2007). In the context of the 
intestine, there are many subsets of myeloid cells with different functions and location. 
Macrophages or several subsets of DCs can be located in the lamina propria (LP) and/or in gut-
associated lymphoid tissues, including PPs (Bekiaris et al., 2014) Based on the expression of 
lysozyme and CD11b, PPs contain particular subsets of DCs (Bonnardel et al., 2015b, 
Bonnardel et al., 2015a, Da Silva et al., 2017). However, the particular subset of myeloid cells 
and the host signalling pathways linking recognition of commensal microbes to the induction of 
IL-17 and IL-22 production by RORγt+ cells in steady state are poorly understood. Here, we aim 
to analyse the role of Mincle to this process (Fig. 4.2.1). Deciphering the contribution of Mincle 
to commensal microorganisms-induced tolerance will open new molecular targets for many 
diseases that course with altered mucosal barrier or leaky gut such as obesity (Araujo et al., 
2017). 
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Figure 4.2.1 Contribution of Mincle to regulation of the homeostasis of commensal 
microbiota in the intestine. Picture displaying the six specific objectives: (1-3) Addressing 
microbiota-Mincle interaction and the pattern of expression of Mincle in different intestinal 
myeloid subsets. (4 and 5) Determining how this interaction could influence DCs function, 
Th17 generation and ILCs functionality. (6) Analyzing the effect of Mincle-microbiota 
interaction mediating mucosal barrier function as tolerance mechanisms. IECs, intestinal 
epithelial cells; ILCs, innate lymphoid cells. 
 
4.2.2 Mincle and Syk signalling in DCs control microbiota-driven Th17 differentiation 
We assessed host signalling pathways with the potential to link recognition of commensal 
microbes by myeloid cells with Th17 differentiation. GMCSF bone marrow-derived CD11c+ 
cells from mice lacking MyD88 (Myd88-/-) (Adachi et al., 1998), Syk in the CD11c+ 
compartment (CD11cCre Sykflox/flox, named CD11cΔSyk mice) (Iborra et al., 2012) or WT 
littermates were loaded with chicken ovalbumin class-II peptide (OVA323-339) and co-cultured 
with naive OVA-speciﬁc (OT-II) CD4+ T cells in the presence or absence of specific pathogen 
free (SPF) gut microbiota. While the proliferation of OT-II cells did not differ upon co-culture 
with different GMCSF bone marrow-derived CD11c+ cells (Fig. 4.2.2 A, upper part), OT-II 
cell capacity to produce IL-17 after priming in the presence of gut microbiota was specifically 
blunted in the absence of Syk but not MyD88 in CD11c+ cells (Fig. 4.2.2 A, bottom part). 
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Syk signaling following pattern recognition is characteristic of some C-type lectin receptors 
(CLRs). Syk binds to immunoreceptor tyrosine-based activation motif (ITAM) domains present 
in the FcRγ chain (Fcer1g) adaptor that couples to Dectin-2 (Clec4n) or Mincle (Clec4e), or to 
hemITAMs borne by CLRs, such as Dectin-1 (Clec7a) (Iborra and Sancho, 2015). Thus, we 
explored the ability of GMCSF bone marrow-derived CD11c+ cells lacking Dectin-1 or FcRγ 
chain to promote microbiota-driven Th17 differentiation from naive OT-II cells as above. 
Although proliferation of OT-II cells was similar (Fig. 4.2.2 B, upper part), microbiota-
induced Th17 differentiation was dependent on the expression of the FcRγ chain but not Dectin-
1 in CD11c+ cells (Fig. 4.2.2 B, bottom part). We subsequently found that, upstream the FcRγ 
chain, Mincle, but not Dectin-2, was needed in GMCSF bone marrow-derived CD11c+ cells for 
microbiota-driven Th17 differentiation in vitro (Fig. 4.2.2 C, upper and bottom parts). 
Notably, exposure to microbiota induced Syk phosphorylation in GMCSF bone marrow-derived 
CD11c+ cells in a Mincle-dependent manner (Fig. 4.2.2 D).  
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Figure 4.2.2. Mincle and Syk signaling in GMCSF bone marrow-derived CD11c+ cells 
control microbiota-driven Th17 differentiation. (A-C) Naive OT-II T cells were co-cultured 
with GMCSF bone marrow-derived CD11c+ (1:2 ratio) from the indicated genotypes loaded 
with OVA peptide and in the presence or not of microbiota (10:1 CD11c+ cells ratio) and IL-17 
was measured by ELISA in the supernatant 3d later. Top: Representative FACS plots showing 
Celltrace Violet dilution in OT-II T cells co-cultured with CD11c+ cells from the indicated 
genotypes (D) Representative confocal images of Syk phosphorylation (red) in GMCSF bone 
marrow-derived CD11c+  from WT and Mincle-deficient (Clec4e-/-) mice, 30 minutes after 
stimulation or not (medium) with zymosan (10 µg/mL) or gut microbiota (10:1 CD11c+ cells 
ratio). DAPI was used for nuclear counterstaining. Merged image with DAPI, P-Syk and 
visible; (scale bar = 5 µm; Clec4e-/- plus microbiota: 2 µm) (A-C) Individual data representing 
data generated from independent GMCSF cultures (biological replicates) in pools of at least two 
independent experiments. Individual data and arithmetic mean are shown. *** p < 0.001 (One-
way ANOVA and Bonferroni post-hoc test); (D) One representative experiment of at least three 
performed.  
GMCSF bone marrow-derived cells comprise conventional DCs (GM-DCs) and monocyte-
derived macrophages (GM-Macs) (Helft et al., 2015). GM-Macs expressed Mincle 
constitutively, while intestinal microbiota stimulation induced Mincle expression in GM-DCs 
(Fig. 4.2.3 A) as expected (Helft et al., 2015). In addition, we found that GM-DCs efficiently 
primed IL-17 and IL-22 production by OT-II cells in response to microbiota and in a Mincle-
dependent fashion (Fig. 4.2.3 B-D). In contrast, GM-Macs promoted IFN-γ-producing OT-II 
cells in a Mincle-independent manner (Fig. 4.2.3 E). These results suggest that the Mincle-FcRγ 
chain-Syk axis in GM-DCs drives Th17 differentiation in response to intestinal commensals. 
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Figure 4.2.3. Mincle and Syk signaling in DCs direct microbiota-driven Th17 
differentiation. (A) Representative histograms showing Mincle or isotype staining for the 
indicated populations. (B-E) Naive OT-II T cells were co-cultured with GM-Macs or GM-DCs 
(1:1 ratio) loaded with OVA peptide and in the presence or not of microbiota (10:1 cell ratio) 
and IL-17 was measured by ELISA in the supernatant 3 days later (B). IL-17 (C), IL-22 (D) and 
IFN-γ (E) production after re-stimulation was measured by intracellular staining and flow 
cytometry in OT-II T cells from the co-cultures. Left: representative plot, right: quantification. 
(A) One representative experiment of at least three performed; (B-E) Individual data 
representing data generated from independent GMCSF cultures (biological replicates) in pools 
of at least two independent experiments. Individual data and arithmetic mean are shown. *** p 
< 0.001 (One-way ANOVA and Bonferroni post-hoc test).  
4.2.3 Mincle senses mucosa-associated commensals  
We tested whether whether Mincle could bind to the intestinal microbiota from our SPF mice. 
Mincle ectodomain-human Fc chimera (Mincle-hFc) recognized the microbiota in a dose-
dependent manner (Fig. 4.2.4 A). Pre-incubation of Mincle-hFc with 2F2 anti-Mincle antibody 
or with the Mincle ligand TDB specifically prevented its binding to the microbiota (Fig. 4.2.4 
B). In addition, Mincle-hFc did not bind to the gastrointestinal content from germ-free mice 
(Fig. 4.2.4 B).  Notably, the analysis of small intestine mucosa from SPF mice revealed a more 
than three-fold average enrichment in Mincle-hFc labelled commensals compared to parallel 
staining of the luminal fraction mice (Fig. 4.2.4 C, D).We additionally found that a fraction of 
luminal but not mucosa-associated microbiota was detected by hFc-chimeras of the Syk-coupled 
CLRs Dectin-1 and Dectin-2 (Fig. 4.2.4 E). Comparative 16S sequencing analysis of Mincle-
hFc-bound and -depleted microbial fractions, along with a control-hFc-bound fraction, revealed 
that Lactobacillus was one of the main genera enriched in Mincle-hFc-bound fraction (Fig. 
4.2.4 F). Mincle-hFc stained Lactobacillus recovered from the small intestine epithelium of 
mice orally gavaged with Celltrace Violet-labeled Lactobacillus plantarum (L.plantarum) but, 
intriguingly, not the same bacteria growing in MRS Broth (Fig. 4.2.4 G). These results indicate 
that some phyla of mucosa-associated commensals, including Lactobacillus, may contain 
ligands for Mincle (Shah et al., 2016). 
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Figure 4.2.4 Mincle recognizes mucosa-associated commensals (A) Representative plots (left 
panels) and graph depicting the frequency of SPF microbiota stained with Control-hFc or 
Mincle-hFc. Arithmetic mean + SEM of pool of 3 replicates from 2 independent experiments. 
(B) Frequency of microbiota stained with Control-hFc or Mincle-hFc as indicated. Left: after 
pre-incubation with titrated dilutions of anti-human Mincle (clone 2F2) or an isotype control 
antibody; middle: after pre-incubation with decreasing doses of TDB (half dilution starting 1 
mg/ml); right: in the intestinal content from SPF and GF mice.(C) Analysis by stimulated 
emission depletion super-resolution microscopy of mucosa-associated commensals from SPF 
mice labeled with Control-hFc or Mincle-hFc. Scale bar: 2 µm. (D) Frequency of luminal and 
mucosal microbiota from SPF mice stained with Control-hFc or Mincle-hFc by flow cytometry. 
(E) Frequency of luminal or mucosa-associated microbiota stained with the indicated Fc 
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chimeras.(F) Luminal microbiota was stained as in (A), sorted into Mincle-hFc-enriched 
(Mincle-hFc+), Mincle-hFc-depleted (Mincle-hFc-) and Control-hFc-enriched (Control-hFc+) 
fractions and analyzed by 16S sequencing. Left: Relative abundance of each genus from two 
independent experiments. Right: Enrichment index and specificity index, calculated as 
explained in Methods. (G) Mucosa-associated commensals from WT SPF mice gavaged with 
Celltrace violet-labeled Lactobacillus plantarum (L. plantarum) or in vitro-grown L. plantarum 
were stained with control-hFc or Mincle-hFc and analyzed by flow cytometry. Left: 
representative staining. Right: frequency of bacteria positive for the indicated staining, pre-
gated on cell violet-positive bacteria. (B-D,G) One representative experiment of two performed. 
(E) Pool of two independent experiments. * p < 0.05; ** p< 0.01; *** p < 0.001 (B) Unpaired 
two-tailed Student´s t test; (E) One-way ANOVA and Bonferroni post-hoc test. 
4.2.4 Mincle is expressed in Peyer’s Patches DCs 
Lactobacillus exhibit a preferential binding to the follicle-associated epithelium of the Peyer´s 
patches (PPs) (Plant and Conway, 2001). We hypothesized that Mincle-expressing cells sensing 
mucosa-resident commensals could be located in the gut-associated lymphoid tissue. Indeed, 
Mincle was expressed in PPs and FcR chain-dependent Mincle expression was restricted to the 
CD11c+ MHCII+ CD19- CD11b+ subset in PPs (Fig. 4.2.5 A). Confocal microscopy of PPs 
whole mount preparations confirmed the selective Mincle expression in the CD11c+ CD11b+ 
immune compartment (Fig. 4.2.5 B). Concurring with previous published results (Bonnardel et 
al., 2015b), Mincle was mainly expressed by some Lysozyme-expressing macrophages 
(LysoMacs), DCs (LysoDCs) and dome CD11b+ DCs, but not dome CD8α+ DCs (Fig. 4.2.5 C). 
In contrast, Mincle expression in small intestine LP was mainly found on macrophages but not 
in CD64- DC subsets (Fig. 4.2.5 D, E). Mincle expression in human intestinal samples from 
healthy donors was revealed in a fraction of CD45+ CD64- CD14- CD11c+ HLA-DR+ cells by 
flow cytometry (Fig. 4.2.5 F).These results indicate that Mincle is expressed by macrophages in 
PPs and small intestine LP, and some DCs in the mouse PPs. 
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Figure 4.2.5 Mincle is expressed in Peyer’s Patches DCs (A) Mincle expression in the 
indicated genotypes by flow cytometry in PPs. Left: Representative plots. Right: Mean 
Fluorescence intensity (MFI). (B) Representative confocal images showing whole mount 
preparations of PPs from WT and Mincle-deficient (Clec4e-/-) mice stained with anti-Mincle 
antibody (clone 1B6) (green), CD11b (red) and CD11c (pink) co-stained with DAPI (blue); 
(scale bar = 20 µm). (C) Mincle expression by flow cytometry in the myeloid populations from 
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WT mice PPs. Left: Representative plot. Right: Frequency of Mincle+ cells in the depicted 
subset. (D) Left: Gating strategy used to identify the small intestine mouse LP Monocytes (Mo), 
intermediates Mo (iMo) and Macrophages (Mac). Right: Representative dot plot showing 
Mincle expression (black) or its isotype control (blue) in the indicated populations. (E) 
Frequency of Mincle+ cells in the myeloid subsets from WT small intestine LP. (F) Mincle 
expression in LP mononuclear cells from 3 colonic and 3 duodenal samples from healthy 
individuals by flow cytometry. Left: gating strategy. Middle: Mincle vs Fluorescence Minus 
One (FMO) expression in the CD11c- HLA-DR- and CD11c+ HLA-DR+ populations. Right: MFI 
of Mincle expression or the FMO in six independent samples. (A, C, E) At least two 
independent experiments have been pooled. (B, D, J) One representative experiment of two 
performed. (A, F) * p < 0.05; ** p < 0.01 (Unpaired two-tailed Student´s t test) 
4.2.5 DCs from PPs instruct Mincle- and Syk-dependent Th17 differentiation  
Next, we explored the contribution of freshly isolated dome CD11b+ DCs, dome CD8α+ DCs, 
LysoMacs and LysoDCs from PPs to prime OT-II CD4+ T cells ex vivo. Dome CD11b+ DCs 
and LysoDCs had a higher capacity to induce IL-17 production by CD4+ T cells compared to 
CD8+ DCs and LysoMacs (Fig. 4.2.6 A).  Moreover, the ability of CD11b+ DCs and LysoDCs 
to promote Th17 differentiation was dependent on Mincle and Syk (Fig. 4.2.6 A, B), whereas 
Th1 differentiation induced by these cells was Mincle- and Syk-independent (Fig. 4.2.6 C). 
These results suggest that dome CD11b+ DCs and LysoDCs located in PPs mediate Mincle and 
Syk-dependent Th17 differentiation. 
4.2.6 Mincle fosters IL-6 and IL-23p19 production by DCs in response to microbiota 
The cytokine IL-6 plays a non-redundant role in Th17 differentiation in gut mucosa (Hu et al., 
2011, Persson et al., 2013) and CD11b+ DCs from PPs are superior at producing IL-6 compared 
with other DC subsets from PPs or splenic DCs (Sato et al., 2003). Conversely, activation of 
ILC3s is independent of IL-6 but dependent on microbiota-induced IL-23p19 (Klose and Artis, 
2016). Therefore, we explored whether both instructing signals were produced in a Mincle-
dependent manner in PPs. Mincle-deficient mice exhibited reduced IL-6 and IL-23p19, but 
similar TGF-β and IL-12p40 transcripts in PPs compared with WT littermates (Fig. 4.2.6 D). 
Consistent with this, IL-6 protein production by CD19- CD11c+ MHCII+ DCs in PPs was 
diminished in Mincle-deficient mice compared with WT littermates, whereas IL-12p40 
production was not affected (Fig. 4.2.6 E, F). Accordingly, microbiota induced Mincle-
dependent IL-6 and IL-23 production by GM-DCs (Fig. 4.2.6 G). These results indicate that 
steady state microbiota triggers Mincle-dependent IL-6 and IL-23p19 expression, which could 
instruct IL-17 and IL-22 production. 
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Figure 4.2.6. DCs from PPs instruct Mincle- and Syk-dependent Th17 differentiation (A-
C) Naive OTII T cells were co-cultured 3 days with dome CD11b+ DCs, CD8α+ DCs, LysoMacs 
or LysoDCs from the indicated genotypes, sorted from PPs (1:1 ratio) and loaded with OVA323-
339 peptide. (A, B upper part) Representative FACS plots of IL-17 (A) and IL-22 (B) 
intracellular staining after OTII restimulation. (A, B bottom) Summary graph showing the 
percentage of IL-17+ (A) or IL-22+ (B) after PMA and ionomycin stimulation measured by 
intracellular staining and flow cytometry. (C) IFN-γ production after PMA and ionomycin 
stimulation. (D), Il6, Il23a, Tgfb and Il12b transcripts in PPs of the indicated genotypes by 
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qPCR normalized to Gapdh. (E, F) Analysis of IL-6 (E) and IL-12p40 (F) intracellular staining 
in CD11c+ MHC-II+ CD19- cells from PPs in the indicated genotypes. (E, left) representative 
histograms. (E, F right) Mean fluorescence intensity (MFI) of staining. (G) ELISA of IL-6 and 
IL-23 production by sorted GM-DCs from WT and Mincle-deficient (Clec4e-/-) mice untreated 
(medium) or stimulated with gut microbiota (10:1 DC ratio) during 12 hours. (A, B, D-G) One 
representative experiment of at least three performed. (C) Two independent pooled experiments. 
(A, B) One-way ANOVA and Bonferroni post-hoc test. (D, E, G) Unpaired two-tailed Student´s 
t test.* p < 0.05; ** p < 0.01; *** p < 0.001. 
4.2.7 Mincle and Syk in DCs are needed for intestinal IL-17 and IL-22 production  
We next explored whether the absence of Mincle and Syk in the CD11c+ compartment could 
affect Th17 differentiation in the steady state intestine in vivo. IL-17 and IL-22 production by 
both CD4+ T cells from PPs and sorted CD3+ T cells from the small intestine LP was reduced 
both in CD11cΔSyk mice (Fig. 4.2.7 A) and in Mincle-deficient mice  (Fig. 4.2.7 B) compared 
with WT littermates, while IFN-γ production was not altered (Fig. 4.2.7 C, D). IL-17 producing 
T cells generated in a Mincle-dependent manner in the steady state mainly co-produced IL-10, 
but not IFN-γ, indicating that these T cells were non-pathogenic (McGeachy et al., 2007) (Fig. 
4.2.7 E). Naive CD4+ T cells from both CD11cΔSyk and Mincle-deficient mice differentiated 
normally into IL-17- and IL-22-secreting effector cells in the presence of Th17-polarizing 
cytokines (Fig. 4.2.7 F). Furthermore, adoptively transferred naive CD4+ T cells from 
CD11cΔSyk mice or WT littermates (CD45.2+) similarly produced IL-17 and IL-22 in PPs of 
WT recipients (CD45.1) (Fig. 4.2.7 G). These results exclude an intrinsic defect of cytokine 
production in the T cells of these mice.  
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Figure 4.2.7 Mincle and Syk in DCs are needed for intestinal T cells-mediated IL-17 and 
IL-22 steady state production. (A, B) Left: representative plots and summary graph of IL-17 
and IL-22 production by intracellular staining after PMA and ionomycin stimulation in CD4+ T 
cells from PPs; right: or small intestine lamina propria sorted CD3+ T cells, in the indicated 
genotypes. (C, D) Left: IFN-γ production by intracellular staining after PMA and ionomycin 
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stimulation in CD4+ T cells from PPs; right: or small intestine lamina propria sorted CD3+ T 
cells, in the indicated genotypes. (E) IL-17, IFN-γ and IL-10 production by intracellular staining 
after PMA and ionomycin stimulation in CD4+ T cells from PPs in the indicated genotypes. (F) 
IL-17 and IL-22 production by naive CD4+ T cells from the indicated genotypes stimulated in 
vitro on plate-bound anti-CD3 and anti-CD28 under Th17 polarizing conditions for 5 days and 
restimulated for intracellular staining. (G) IL-22 and IL-17 production by intracellular staining 
of restimulated CD45.2+ CD4+ in the PPs 14 days after adoptive transfer of 6x106 naive CD4+ T 
cells purified from CD45.2+ WT and CD11cΔSyk to CD45.1 recipients. (A, B, E, G)  At least 
two independent experiments have been pooled. (C, D, F) One representative experiment of at 
least two performed is shown.  Each symbol represents an individual mouse. The arithmetic 
mean for each group is indicated. ** p < 0.01; *** p < 0.001 (Unpaired two-tailed Student´s t 
test) 
Additional sources of IL-17 and IL-22 in the gut are CCR6-expressing ILC3s that are mainly 
located in PPs (Klose and Artis, 2016). CD11cΔSyk and Mincle-deficient mice exhibited 
reduced frequencies of IL17- or IL17/IL22-producing ILCs in both PPs and small intestine LP 
compared with WT littermates, whereas ILCs producing only IL-22 were comparable between 
genotypes (Fig. 4.2.8 A, B). These results reveal that the Mincle-Syk signaling pathway 
regulates IL-17 and IL-22 production by both innate and adaptive cellular sources in the steady-
state small intestine and PPs.  
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Figure 4.2.8 Mincle and Syk in DCs are needed for intestinal ILCs-mediated IL-17 steady 
state production. (A, B)  Left: frequency of CCR6+ ILCs from PPs; right: from the small 
intestine lamina propria, producing IL-22 and IL-17 in steady state by intracellular staining in 
the indicated genotypes. (A, B) At least two independent experiments have been pooled. Each 
symbol represents an individual mouse. The arithmetic mean for each group is indicated. ** p < 
0.01; *** p < 0.001 (Unpaired two-tailed Student´s t test). 
4.2.8 Mincle-dependent IL-17 producing-cells in PPs require commensal bacteria 
Treatment with a broad-spectrum antibiotic cocktail to disrupt the gut microbiota abolished IL-
17 production by T cells from PPs in WT littermates to the levels found in Mincle-deficient and 
CD11cΔSyk mice (Fig. 4.2.9 A, B), suggesting that PP Th17 cell development required 
intestinal bacteria. Given the prominent role of SFB in Th17 cell differentiation in PPs (Ivanov 
et al., 2009), we investigated the potential involvement of SFB in the Mincle-dependent Th17 
differentiation. SFB was detected in our mouse colonies by PCR (IDEXX Bioresearch). SFB is 
sensitive to vancomycin treatment as demonstrated by the decrease in SFB content in feces after 
treatment (Fig. 4.2.9 C) (Ivanov et al., 2008). Notably, vancomycin treatment slightly reduced 
IL-17 production by CD4+ T cells from PPs of WT littermates, with the remaining IL-17 
production dependent on Mincle (Fig. 4.2.9 D). These results show that vancomycin resistant 
bacteria mediate Mincle-dependent IL-17 production by T cells from PPs.  
Figure 4.2.9 Mincle-dependent maintenance of IL-17 producing-cells in PPs does not 
require SFB. . (A, B, D) Frequency of IL-17 production by intracellular staining in 
restimulated CD4+ T cells from PPs of the indicated genotypes after treatment with an antibiotic 
cocktail (ABX) containing ampicillin, neomycin, metronidazole and vancomycin (A,B) or 
vancomycin only (D) in the drinking water during 4 weeks. (C) SFB DNA was quantified by 
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qPCR in feces from Mincle-deficient (Clec4e-/-) and WT littermate in steady state or after 
vancomycin administration as described above. The lower line indicates the limit of detection 
(LOD).  (A,B) One representative experiment of two performed. (C, D) At least two 
independent experiments have been pooled. Each symbol represents an individual mouse. The 
arithmetic mean for each group is indicated. * p < 0.05; ** p < 0.01; *** p < 0.001 (A,B,D) 
One-way ANOVA and Bonferroni post-hoc test.  (C) Two-tailed Mann-Whitney´s U test. 
Given the binding of Mincle-hFc to L. plantarum (Fig. 4.2.4 G), we tested the ability of 
mucosal-associated commensals from WT mice treated with ABX during gestation and lactation 
and gavaged with L. plantarum at weaning (L. plantarum-enriched mucus) to induce Th17 
differentiation in vitro. For this, naive OT-II T cells were stimulated with sorted GM-DCs from 
WT and Mincle-deficient (Clec4e-/-) mice pulsed or not (medium) with L. plantarum-enriched 
mucus and loaded with OVA323-339 peptide. We found that L. plantarum-enriched mucus induced 
IL-17 and IL-22 production by naive OT-II cells upon culture with WT but not Mincle-deficient 
GM-DCs (Fig. 4.2.10 A). Induction of Th17 differentiation correlated with Mincle-dependent 
production of IL-6 and IL-23 by GM-DCs (Fig. 4.2.10 B). Moreover, mice treated with ABX 
and gavaged with L. plantarum at weaning as indicated above showed a Mincle-dependent 
induction of IL-17 and IL-22 production by CD4+ T cells and CCR6+ ILCs in PPs compared 
with controls not gavaged with L. plantarum (Fig. 4.2.10 C,D), without impacting IFN-γ 
production (Fig. 4.2.10 E). These results suggest that mucosa-associated bacteria, including L. 
plantarum, drive Mincle-dependent IL-17 and IL-22-producing cells in PPs. 
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Figure 4.2.10 Mincle-dependent IL-17 producing-cells in PPs requires mucosa-associated 
commensal bacteria. (A)  Frequency of IL-17 and IL-22 production by intracellular staining of 
restimulated OT-II T cells co-cultured with sorted GM-DCs from WT and Mincle-deficient 
(Clec4e-/-) mice loaded with OVA323-339 peptide, which were pulsed or not (medium) with 
mucosal-associated commensals from WT mice treated with ABX during gestation and lactation 
and gavaged with L. plantarum at weaning as indicated (L. plantarum-enriched mucus; 10:1 DC 
ratio). (B) ELISA of IL-6 and IL-23 from the co-culture of GM-DC in (A). (C-E) WT 
littermates and Mincle-deficient (Clec4e-/-) mice were treated with ABX during gestation and 
lactation and were gavaged with L. plantarum (1x106) at weaning as indicated in the scheme (+ 
L. plantarum gavage). Frequency of IL-17- and IL-22-producing restimulated CD4+ T cells (C) 
or CCR6+ ILCs (D) and IFN-γ production by CD4+ T cells (E) from PPs by intracellular staining 
in the indicated genotypes and conditions. (A-C) At least two independent experiments have 
been pooled; (D, E) One representative experiment of two performed. Each symbol represents 
an individual mouse. The arithmetic mean for each group is indicated. * p < 0.05; ** p < 0.01; 
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*** p < 0.001 (A-C) One-way ANOVA and Bonferroni post-hoc test.  (D) Unpaired two-tailed 
Student´s t test.  
4.2.9 The Mincle-Syk axis contributes to the intestinal barrier function 
We next explored whether the defective IL-17 and IL-22 expression in Mincle-deficient and 
CD11cΔSyk mice affected the intestinal barrier function. To explore the immunological barrier, 
we examined the expression of antimicrobial peptides in the intestine, specifically RegIII, 
whose production relies on RORt-dependent cells (Sanos et al., 2009). We found that steady-
state Reg3g expression was reduced in the absence of Mincle or Syk in CD11c+ cells compared 
with WT littermates (Fig. 4.2.11 A). Notably, oral administration of L. plantarum to ABX-
treated weaned mice as above promoted Reg3g expression in a Mincle-dependent manner (Fig. 
4.2.11 B). IgA secretion can be influenced directly by Th17 cells and ILC3 (Hirota et al., 2013, 
Kruglov et al., 2013). Total IgA was reduced in the intestinal lumen in Mincle-deficient and 
CD11cΔSyk mice compared with WT littermate controls (Fig. 4.2.11 C). Flow cytometry 
analysis of the frequency of IgA-coated intestinal bacteria, which was dependent on Aicda, 
revealed a specific reduction in the absence of Mincle (Fig. 4.2.11 D). Frequency of IgA+ 
plasma cells in the small intestine LP of Mincle-deficient and CD11cΔSyk mice was decreased 
compared with WT littermates (Fig. 4.2.11 E), while IgG+ plasma cells were comparable (Fig. 
4.2.11 F). This correlated with reduced percentages of PD-1hi CD4+ T cells in PPs (Fig. 4.2.11 
G), a marker of T follicular helper (Tfh) cells that promote IgA-producing germinal center B 
cells (Hirota et al., 2013). These differences in gut immunity did not result in significant 
differences in the luminal microbiota composition at the genus level between Mincle-deficient 
mice and their WT littermates (Fig. 4.2.11 H). These results indicate that the Mincle-Syk 
signaling pathway contributes to maintain a functional intestinal immune barrier, but does not 
play a major role in regulating intestinal microbiome composition. 
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Figure 4.2.11. The Mincle-Syk axis contributes to the intestinal barrier function. (A, B) 
Reg3g transcripts were measured by qPCR normalized to Gapdh in the jejunum of the indicated 
genotypes during steady state (A) or after L. plantarum gavage, as described in the scheme (B).  
(C) Quantification of total IgA measured by ELISA in the intestinal lumen of the indicated 
genotypes. (D) Frequency of IgA+ bacteria by flow cytometry in the indicated genotypes. (E, F) 
Representative plots and summary graphs of CD45+B220-IgA+ (E) or IgG+ (F) plasmatic cells 
from the small intestine LP of the indicated genotypes. (G)  Representative plots and summary 
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graph of CD4+PD-1high T cells from PPs of the indicated genotypes. (H) 16S sequencing analysis 
of intestine luminal microbiota from Mincle-deficient (Clec4e-/-) mice and their WT littermates. 
Graph showing the mean relative abundance of each genus in each sample (at least 10 mice 
pooled) from two independent experiments. (A-G) Data pooled from at least two independent 
experiments. Individual mice and arithmetic mean of each group is indicated. * p < 0.05; ** p< 
0.01; *** p < 0.001(A,B) One-way ANOVA and Bonferroni post-hoc test (C-G) Unpaired two-
tailed Student´s t test.  
4.2.10 Mincle-Syk pathway promotes commensal bacteria containment 
To explore whether the functional impairment of the intestinal barrier in Mincle-deficient and 
CD11cΔSyk mice affects microbial containment in the intestine, we first analyzed the presence 
of live facultative aerobe bacteria in extra-intestinal organs. We found increased microbe 
translocation to the liver in the absence of Mincle or Syk in DCs compared to WT littermate 
controls (Fig. 4.2.12 A, B). Deep 16S rRNA sequencing revealed that most of the surplus 
disseminated aerobe bacteria found in the liver of Mincle-deficient mice belonged to the phylum 
Proteobacteria either following growth in LB medium or by direct sequencing of fresh liver 
homogenates (Fig. 4.2.12 C). As an additional readout for systemic dissemination of 
commensals (Zeng et al., 2016), we found increased intestinal bacteria-specific IgG in sera of 
Mincle-deficient and CD11cΔSyk mice compared with WT littermates (Fig. 4.2.12 D). 
Next, we analyzed whether the presence of increased intestinal commensals in the liver of 
Mincle-deficient mice can lead to patho-physiological alterations. CD45+CD11bhigh myeloid 
cells, mainly neutrophils and inflammatory monocytes, were increased in the liver of Mincle-
deficient mice compared with WT littermates in an ABX-dependent manner (Fig. 4.2.12 E). 
Liver inflammation in the absence of Mincle correlated with moderate liver malfunction 
reflected by an increased total, but not direct, serum bilirubin, without affecting serum 
ALT/AST levels (Fig. 4.2.12 F). Some lipid metabolism-related genes such as Scd1 (Stearoyl-
CoA desaturase-1) or Cpt1a (Carnitine palmitoyltransferase 1) were significantly upregulated in 
the liver of Mincle-deficient mice (Fig. 4.2.12 G). This increased expression of lipogenic genes 
correlated with an accumulation of diacylglycerides (DAG) (Fig. 4.2.12 H), and some fatty 
acids including margaric and linoleic acids in Mincle-deficient mice (Fig. 4.2.12 I), as revealed 
by metabolomics assays. These results indicate that the intestinal immune barrier fostered by 
Mincle/Syk axis limits microbial translocation, preventing systemic inflammation and 
promoting host-microbiota mutualism. 
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Figure 4.2.12. Mincle-Syk pathway promotes commensal bacteria containment. (A, B) 
Bacterial translocation into the liver of Mincle-deficient mice (Clec4e-/-) (A) or CD11cΔSyk (B) 
and WT littermates. Left: bacterial load as colony forming units (CFUs) per organ, indicating 
limit of detection (LOD). Right: Frequencies of mice of each genotype showing more than 40 
CFUs per organ (=2xLOD). (C) 16S rRNA sequencing analysis of LB-grown commensals from 
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the liver (left) or bacterial DNA directly extracted from the liver (right) in the indicated 
genotypes. The graph shows the percentage of total reads corresponding to each phylum. Each 
bar represents 4 pooled LB plates/mouse and 4 mice/sample of each genotype (LB-grown 
commensals) or 6 pooled mice per genotype (Commensals from the liver). (D) ELISA of serum 
IgG against intestinal bacteria in the indicated genotypes. (E) Summary graph of CD45+ 
CD11bhigh Ly6G+ cells (left) or Ly6C+ cells (right) infiltrated in the liver of Mincle-deficient 
(Clec4e-/-) and their WT littermates in steady state or after administration of an antibiotic 
cocktail (ABX). (F) Total (left) or direct (right) bilirubin in the indicated genotypes. (G) 
Alanine transaminase (ALT/GPT) (left) and Aspartate transaminase (AST/GOT) (right) 
analyzed in serum of the indicated genotypes. (H) Acc, Fas, Scd1, Srebpc, G6pase, Pepck, 
Cpt1a and Ppara transcripts were analyzed by qPCR and normalized to Gapdh in the liver of 15 
mice of the indicated genotypes in 3 independent experiments. (I, J) Individual lipid species of 
diacylglycerides (DAG) (I) and free fatty acid classes, Margaric (C17:0) and Linoleic (C18:2) 
acids (J) measured by LC-MS and GC-MS metabolomics-based profiling approach. Data 
presented as metabolites’ abundance. (A-J) Data are pooled from at least two independent 
experiments. * p < 0.05 ** p< 0.01; *** p < 0.001. (A-D, F-H margaric acid) Unpaired two-
tailed Student´s t test; (H linoleic acid) Mann−Whitney U-test; (E) One-way ANOVA and 
Bonferroni post-hoc test.  
 
 
 
 
 
 
 
 
 
 
 
 
 
114 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Discussion 
116 
 
5. DISCUSION 
The skin and the gastrointestinal tract are barrier tissues that are the entrance of pathogenic 
microorganisms but at the same time are the niche for beneficial microorganisms that composed 
the commensal microbiota. In this situation, the immune system has to face a big challenge, 
eliminating pathogenic microbes and foreign substances, while avoiding damage of self-tissues 
and facilitating the symbiosis to resident microbiota (Belkaid and Artis, 2013). For that, sensing 
of the environmental cues is essential. 
Myeloid cells are professional sensors of the environment. For that, they are equipped with a 
variety of germ line-encoded receptors, called pattern recognition receptors (PRRs) that allow 
them to detect surrounding milieu signals. Although, Charles Janeway hypothesised the 
existence of these receptors initially as sensors of “non-self” pathogen-associated molecular 
patterns (PAMPs) on pathogens as inducers of immunity (Janeway, 1989), PAMPs are not 
exclusive to pathogens, and are also present in the resident microbiota, referred as microbe-
associated molecular patterns (MAMPs) (Chu and Mazmanian, 2013). In addition, these 
receptors can also detect “self” damage-associated molecular patterns (DAMPs), host cellular 
components released upon cell death (Jounai et al., 2012). Some of these receptors, for example 
several myeloid C-type lectin receptors (CLRs) are promiscuous and versatile receptors that can 
detect “non-self” ligands from pathogens or commensal microorganisms, while at the same time 
are able to sense “self” ligands coming from the host (Del Fresno et al., 2018). Detection of 
PAMPs/MAMPs/DAMPs may lead to myeloid cell activation and maturation, which finally 
shapes the nature of the adaptive response, triggering immunity or promoting homeostasis, 
accordingly to the initial detected signals (Iwasaki and Medzhitov, 2010).  
A prototypical example of this adaptability is the myeloid CLR Mincle. Classically viewed as 
an activating receptor, Mincle senses and responds to several “non-self” ligands derived from 
pathogenic bacteria and fungi. In most of the cases, Mincle-mediated recognition of these 
pathogens promotes the activation of myeloid cells and the generation of immunity against the 
infection (Sharma et al., 2014, Rabes et al., 2015, Behler-Janbeck et al., 2016, Chinthamani et 
al., 2017, Kottom et al., 2017, Bugarcic et al., 2008, Wells et al., 2008, Yamasaki et al., 2009). 
In contrast, Mincle-sensing of “non-self” ligands can lead to immunosuppression by directly 
promoting myeloid cells secretion of anti-inflammatory mediators (Lee et al., 2016b, Devi et al., 
2015) or by indirect inhibition of activating heterologous receptors signalling (Wuthrich et al., 
2015, Wevers et al., 2014), favouring pathogen-mediated immune scape or the resolution of the 
inflammation.  
This duality, promoting and/or inhibiting the generation of immune responses, is not restricted 
to Mincle-recognition of “non-self” ligands, but it is also true in response to “self” derived 
compounds. Upon “self” ligands recognition, Mincle can mediate immunity (Kiyotake et al., 
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2015, Kostarnoy et al., 2017, Nagata et al., 2017), but also immunosuppression (Xie et al., 
2017), even in response to the same endogenous ligand, as described for  SAP-130(Yamasaki et 
al., 2008, Arumugam et al., 2017, Suzuki et al., 2013, Zhou et al., 2016 , Tanaka et al., 2014, 
Lee et al., 2016a, Greco et al., 2016, Seifert et al., 2016).   
This versatility let us to explore the role of Mincle in two different scenarios. First, upon 
Leishmania parasite infection. Some parasites that depend on an invertebrate vector for cyclical 
transmission, have evolved mechanisms to persist in host myeloid cells, by evading, delaying 
and manipulating host immunity in order to escape host resistance and ensure their 
transmission. CLRs expressed on myeloid cells might be critical for Leishmania recognition and 
can be targeted to sabotage the host immune response (Martinez-Lopez et al., 2018). The second 
one in response to commensal microbiota. These microorganisms are well adapted to survive 
inside the host, and have evolved mechanisms to prevent the generation of immunity and 
promote the mutually beneficial relationship; myeloid sensing of the gut microbiota is essential 
in this process (Belkaid and Hand, 2014, Swiatczak and Cohen, 2015). 
For the first objective, we used the parasite Leishmania major (L. major). Leishmania parasites 
replicate silently in the skin for several weeks after inoculation (Belkaid et al., 2000), suggesting 
that they might actively dampen DC recognition or activation (Srivastav et al., 2012), to 
establish a functional immune privilege in the skin (Peters and Sacks, 2006). During this 
“silent” infection, myeloid CLRs as SIGNR3 (mouse Cd209d) can be targeted by Leishmania 
parasites to escape the host immune response by inhibiting the heterologous CLR Dectin-
1(CLEC7A)-mediated inflammation (Lefevre et al., 2013). Accordingly, we have found that L. 
major parasites release a soluble ligand that binds Mincle to dampen the host immune response. 
Importantly, the identified ligand in Leishmania was mainly located in the flagellar pocket, a 
unique site for exocytosis, and was detected in the supernatant from L. major parasite, which 
fits with the described role of Leishmania secreted microvesicles mediating immunosuppression 
for Leishmania invasion by the activation of tyrosine phosphatases, as SHP-1 in macrophages 
(Silverman and Reiner, 2011). 
Mincle-Leishmania interaction changes the intracellular configuration of the receptor. Upon 
interaction with L. major, the ITAM-containing adaptor molecule, FcRγ chain changes to a 
configuration termed inhibitory ITAM instead of interacts with kinase Syk and generates an 
activating signal to promote immunity (Yamasaki et al., 2009). This inhibitory ITAM signalling 
pathway is characterized by partial phosphorylation of  FcRγ chain  and  the ability to recruit  
phosphatases, inhibiting signals through heterologous receptors (Pasquier et al., 2005, 
Kanamaru et al., 2008).We found that Mincle-mediated inhibitory ITAM promotes the 
recruitment of the src homology region 2 domain-containing phosphatase (SHP)-1, suppresses 
DC activation by heterologous activating receptors concomitantly sensing L. major. Mincle 
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deficiency thus favoured stronger DCs activation in response to L. major infection, manifested 
in higher expression of costimulatory molecules, better migration, and priming of a Th1 cell 
response to parasite antigens. Increased Th1 cell-type immunity correlated with reduced parasite 
load and pathology in Mincle-deficient mice (Fig. 5.1). 
These results reveal a new mechanism of Mincle-mediated immunosuppression, based on the 
inhibitory ITAM configuration and SHP1-inhibitory pathway, in response to “non-self” ligands, 
derived from L. major. This is different from a previous pathway described for Mincle-mediated 
inhibition of heterologous receptors in response to Fonsecaea monophora (F. monophora). In 
response to this fungus, Mincle mediates PKB pathway-dependent ubiquitin ligase activation, 
which leads to loss of Dectin-1 mediated-nuclear IRF1 activity, blocking IL12A transcription 
(Wevers et al., 2014). These results suggest that different pathogens can use Mincle to activate 
several intracellular pathways to dampen heterologous receptors-mediated immune response.  
To explain how it is possible, we can speculate that the state of the ligand can affect how the 
ligand interact with the CLR and the downstream signalling generated upon it recognition. 
Soluble and/or monomeric ligands, as is the case of L. major, are poor activators, whereas 
particulate/oligomeric ligands, as could be the case of F. monophora, promote an efficient 
activating signalling (Iborra and Sancho, 2015). Ligand affinity and avidity can affect the 
quantity and duration of signals through the ITAM domain, resulting in differential responses 
(Hamerman et al., 2009, Yamasaki et al., 2004). As described for the FcαRI receptor, which 
associates with the FcRγ chain for signaling, interaction with multimeric ligands stimulates cell 
activation by recruiting Syk, similar what happens upon F. monophora detection via Mincle. In 
contrast, upon interaction with low affinity or avidity ligands, FcRγ chain changes to inhibitory 
ITAM, being able to inhibit signals through heterologous receptors (Pasquier et al., 2005, 
Kanamaru et al., 2008, Blank et al., 2009) which fits with the observed results for Mincle-
mediated inhibitory ITAM configuration, in response to soluble extracellular ligand from L. 
major parasites, which is able to inhibit DC activation upon LPS challenge in a Mincle-
dependent manner. 
The inhibitory ITAM requires transient Syk activation (Ben Mkaddem et al., 2014). We found 
transient Syk association with Mincle following L. major stimulation and that Syk is required 
for SHP1 recruitment to Mincle. However, we found that the overall response of CD11cΔSyk 
DCs to L. major was impaired, maybe due to Syk involvement for other PRRs intracellular 
signaling, as described for Dectin-1(Lefevre et al., 2013). 
Mincle collaborates with MCL for immune responses against TDM (Miyake et al., 2013, 
Miyake et al., 2015). Both receptors form a heteromeric complex that facilitates signalling 
(Lobato-Pascual et al., 2013) and mutually regulate their expression in response to microbial 
challenge (Kerscher et al., 2016a). We found that MCL does not recognize L. major and L. 
major ligand triggers SHP-1 phosphorylation via Mincle in the absence of MCL, indicating that 
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MCL is not direct involved in this process. It is possible that recognition of L. major by Mincle 
(in homo or heteromeric configuration) could trigger a weaker signal than TDM recognition by 
Mincle-MCL heteromer, and this weaker signaling may favor the inhibitory ITAM 
configuration. 
Our results together with previous studies disarm the initial naïve notion that activating 
receptors could mainly sense non-self ligands to trigger the immune response while ITIM-
bearing CLRs could preferentially bind self –ligands to dampen inflammation. Supporting the 
new general view that most CLRs are adaptable structures that can bind both endogenous and 
exogenous ligands, resulting in distinct functional outcomes, not totally but partially depending 
on their intracellular bearing motif (Del Fresno et al., 2018). 
 
For the second objective, we have assessed the role of Mincle in handling the response to “non-
self” MAMPs (Chu and Mazmanian, 2013) from commensal microorganisms. We focus our 
study in the intestinal microbiota, which is the largest population of microorganisms that inhabit 
the body (Thursby and Juge, 2017). The intestinal microbiota contributes to host metabolism, 
resistance to pathogen colonization and host immune system development and homeostasis 
(Baumler and Sperandio, 2016, Honda and Littman, 2016). However, its containment is 
essential and increased microbial translocation is associated with systemic inflammation 
(Sonnenberg et al., 2012). The intestinal epithelial cells (IECs), the mucus layer, the generation 
of antimicrobial peptides and the synthesis of microbe-specific immunoglobulin A (IgA) in the 
Peyer’s patches (PPs) constitute the “mucosal firewall” (Belkaid and Hand, 2014). This barrier 
is regulated by RORγt-dependent cells that include group 3 innate lymphoid cells (ILC3) and T 
helper 17 (Th17) cells, which produce IL-17 and IL-22 regulating the expression of 
antimicrobial peptides and mucin genes, and influencing IgA responses(Hirota et al., 2013, 
Kruglov et al., 2013). The intestinal microbiota critically contributes to the generation and 
function of these cells (Ivanov et al., 2008, Sanos et al., 2009, Satoh-Takayama et al., 2008) 
through myeloid cell-mediated antigen presentation or -derived cytokines such as IL-6 and IL-
23 after MAMPs-PRRs interaction (Ivanov et al., 2006, Persson et al., 2013, Longman et al., 
2014 , Satpathy et al., 2013). The absence of these cells or their mediators can lead to a breach 
of the intestinal barrier, commensal translocation and systemic inflammation (Lochner et al., 
2011, Sonnenberg et al., 2012). The specific myeloid cell subset, as well as the innate sensors 
involved in this process were unknown. 
In this regard, most of the myeloid Syk-coupled CLRs, including Dectin-1(CLEC7A), Dectin-2 
(CLEC6A in human, Clec4n in the mouse) and Mincle (CLEC4E) mainly drive IL-17 
production by T cells in response to pathogens, by modulation of myeloid IL-6 and IL-23 
secretion (Geijtenbeek and Gringhuis, 2016, LeibundGut-Landmann et al., 2007). In addition, 
the CLRs-mediated Syk/CARD9 pathway has been recently identified as protective in the 
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context of inflammation-associated cancer through recognition of commensal fungi (Malik et 
al., 2018) and many myeloid CLRs has been described recognize ligands from the intestinal 
commensal bacteria and fungi (Lightfoot et al., 2015, Konieczna et al., 2015 , Eriksson et al., 
2013, Hütter et al., 2014). The best-characterized example is Dectin-1(CLEC7A)-mediated 
recognition of indigenous fungi and the control of Treg cell differentiation through modification 
of microbiota (Iliev et al., 2012, Tang et al., 2015). However most of the knowledge is based on 
in vitro or DSS-induced colitis studies and how myeloid CLR-microbiota interaction promotes 
tolerance to microbiota is still poorly understood (Smits et al., 2005 , Eriksson et al., 2013). 
Therefore, we investigated whether Mincle could contribute to intestinal microbiota sensing by 
myeloid cells to promote functional responses in RORγt+ cells under homeostatic conditions. 
We found that Syk kinase, used by Mincle for its signalling (Yamasaki et al., 2008), but not 
MyD88, the adaptor molecule needed for most TLR signalling (Kawasaki and Kawai, 2014), is 
a non-redundant innate signal for driving Th17 differentiation in response to intestinal 
microorganisms recognition by DCs. Consistent with previous studies revealing a critical role 
for Syk-coupled CLRs driving Th17 generation after infection (Geijtenbeek and Gringhuis, 
2016, LeibundGut-Landmann et al., 2007), as well as, with the reported role of MyD88 in T 
cells but not in DCs, in Th17 commitment (Hu et al., 2011, Shaw et al., 2012). We provide 
evidence that sensing of “non-self” mucosal-associated commensal bacteria by Mincle in 
myeloid Lysozyme+ DCs and CD11b+ DCs in PPs induces Syk-dependent IL-6 and IL-23, 
cytokines that stimulate intestinal T cells and ILCs to produce IL-17 and IL- 22. Absence of a 
functional Mincle-Syk axis in DCs leads to reduced IL-17 and IL-22 production and impaired 
intestinal immune barrier function, resulting in increased systemic translocation of microbiota, 
hepatic inflammation and metabolic alterations. 
Our results indicate that commensal bacteria containing Mincle ligands have a preferential 
location close to the intestinal mucosa, and it could explain their ability to interact with myeloid 
cells and modulate IL-17 and IL-22 production. It is in agreement with previous publication 
showing that the differential spatial distribution of commensal microbes in the intestine 
influences their capacity to shape host immune responses (Ivanov et al., 2008, Fung et al., 2014, 
Atarashi et al., 2015). In contrast, ligands from commensal microorganisms for other Syk-
coupled CLRs, as Dectin-1 and Dectin-2, are preferentially luminal and not associated to the 
intestinal mucosa, supporting the non-redundant role of Mincle mediating the recognition of 
mucosa-associated commensals. The 16S rRNA sequencing of bacteria enriched by the 
extracellular domain of Mincle indicates that the small intestine adherent Lactobacillus 
(Donaldson et al., 2016) contains a ligand for Mincle. The exposition of the ligand for Mincle 
seems to require transit through the intestine, resembling the described structural adaptations in 
the cell surface composition of bacteria upon different environmental situations (Sengupta et al., 
2013). 
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Our results concur with the presence of GL1 glycolipid in Latobacillus plantarum (L. 
plantarum) that signals through Mincle (Shah et al., 2016) and with previous reports indicating 
that Lactobacillus activates Syk in DCs (Weiss et al., 2012). In addition, β-gentiobiosyl 
diglycerides recognized by Mincle in the commensal fungus Malassezia have structures similar 
to that of the glycolipid anchor of lipoteichoic acids, a major constituent of the cell wall of 
gram-positive bacteria; although lipoteichoic acid does not signal though Mincle, suggesting a 
common ligand for Mincle in the commensal microorganisms (Ishikawa et al., 2013). In 
contrast, we cannot exclude the possibility that not only the described but others ligands from 
Lactobacillus can be sensed by Mincle, as it has been described for Lactobacillus reuteri 
surface mucus adhesins or the Lactobacillus acidophilus surface layer proteins, which interact 
with DC-SIGN or Dectin-2 and SIGNR3 respectively (Bene et al., 2017, Lightfoot et al., 2015).  
Our results indicate that Mincle is expressed in Lysozyme+-DCs (LysoDCs) and -macrophages 
(LysoMacs) and, to a lesser extent, in CD11b+ DCs. These myeloid cell subsets are efficient in 
the capture of antigens and essential to drive the generation of the mucosal immune response 
(Da Silva et al., 2017). Moreover, CD11b+ DCs and LysoDCs, but not LysoMacs, from PPs 
induce Th17 cell differentiation from naive T cells in a Mincle and Syk-dependent fashion, 
consistent with their T cell priming capacity (Da Silva et al., 2017). Similarly, Mincle 
expression by DCs, but not macrophages, contributes to the generation of splenic immunity 
during Mycobacterium bovis infection in mice (Behler et al., 2015). Some Lactobacillus species 
have preferential association with the follicle associated epithelium of PPs (Plant and Conway, 
2001), suggesting that PPs could be the place where these myeloid cells could sense 
Lactobacillus via Mincle. 
Intestinal microbiota recognition by myeloid cells innate sensors is critical for IL-17 and IL-22 
production by RORγt-dependent cells (Ivanov et al., 2008, Sanos et al., 2009, Satoh-Takayama 
et al., 2008). L. plantarum, which possesses a ligand for Mincle (Shah et al., 2016) is able to 
induce Mincle-dependent Th17 differentiation both in vitro and in bacterial microbiota-depleted 
mice (treated with wide-spectrum antibiotics). .Mincle-mediated Th17 generation seems to be 
independent of the described segmented filamentous bacteria (SFB)-induced Th17 cells (Ivanov 
et al., 2008, Gaboriau-Routhiau et al., 2009 , Ivanov et al., 2009). Suggesting that commensals 
location or cell-specific expression of different PRRs can modulate several pathways of T cell 
differentiation. 
Mechanistically, our data indicate that Mincle/Syk pathway promotes IL-6 and IL-23p19 
production by PPs DCs, upon mucosa-associated commensal recognition.  It may explain the 
selective impact in the differentiation of Th17 but not Th1 cells. On the other hand, the 
regulation of IL-23p19 may affect ILCs function, which requires IL-23R signaling for IL-22 
and/or IL-17 secretion (Longman et al., 2014, Satpathy et al., 2013). 
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Consequently, in the absence of the Mincle or Syk in CD11c+ cells, we found reduced 
production of IL-17 and IL-22, affecting the intestinal barrier. At the level of antimicrobial 
peptides secretion, we found impaired Reg3g expression, which is regulated by IL-22 (Sanos et 
al., 2009). In addition, we found impaired IgA generation, which correlated with a reduction in 
the frequency of IgA+ plasma cells in the small intestine and the proportion of T follicular 
helper cells (Tfh) in PPs in the absence of Mincle and Syk in CD11c+ cells. These results concur 
with previous published studies indicating that Tfh differentiation requires interaction with 
CD11b+ DCs and IL-6 (Krishnaswamy et al., 2017) and the described contribution of the Th17 
cell to Tfh in PPs (Hirota et al., 2013).  
IL-17 and IL-22 deficiency in the absence of Mincle or Syk in CD11c+ cells correlates with 
increased peripheral dissemination of commensal bacteria as described previously that occur in 
the absence of RORγt-dependent cells or their mediators (Lochner et al., 2011, Sonnenberg et 
al., 2012). Commensal translocation correlates with higher liver inflammatory infiltration in 
Mincle-deficient mice, concurring with a recent report indicating that Lactobacillus-dependent 
IL-22 secretion by ILCs can prevent liver inflammation by promoting the intestinal barrier 
(Nakamoto et al., 2017). Interestingly, we found that excess liver inflammation driven by 
commensal translocation is associated to moderate liver malfunction and changes in the hepatic 
lipid metabolism, consistent with previous studies suggesting that increased intestinal 
permeability, bacterial translocation and inflammation can affect hepatic metabolism (Talukdar 
et al., 2012, Pierantonelli et al., 2017). Our results together with previous studies change the 
initial view of the ITAM-coupled CLRs as activating receptors, sensing non-self ligands in 
pathogens to trigger the immunity and show myeloid CLRs as adaptable structures that can bind 
exogenous ligands not only in pathogens but also in commensals microorganisms promoting the 
mutualistic relationship and preventing systemic inflammation (Iborra and Sancho, 2015)  (Fig. 
5.2). 
Altogether, our results are relevant to consider for therapeutically exploitation of 
Mincle. Several synthetic ligands of Mincle have been generated to specifically enhance 
immune response in vaccines preparations (Ostrop et al., 2015, Korsholm et al., 2014). 
For vaccine design, the presence of the Leishmania ligand for Mincle may contribute to the low 
effectiveness of candidate vaccines based on whole killed Leishmania or attenuated parasites 
(Duthie et al., 2012). Our results indicate that blocking Mincle or SHP1 during a vaccination 
setting may improve vaccine efficiency by avoiding Leishmania-Mincle-dampening of the 
adaptive response, although only a few drug-like molecules have been developed for CLRs, 
high in silico druggability scores were found (Lang et al., 2011, Aretz et al., 2014). On the other 
hand, the elucidation of the new Mincle and Syk signaling pathway sensing mucosa-associated 
bacteria that prevents systemic inflammation and its metabolic consequences, allows us to 
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speculate with the possibility to target Mincle-expressing DCs with Lactobacillus-derived 
glycolipids to promote the functionality of the intestinal barrier for diseases associated with 
increased bacterial translocation, such as metabolic disorders (Burcelin, 2016). 
Altogether, our findings suggest that Mincle can couple to an activating ITAM or to an 
inhibitory ITAM configuration depending on the nature of the ligand, and that the same 
activating ITAM does not predispose the response of the coupled CLR. If not the CLR-mediated 
response depend on the context, for example, signals derived from healthy or infected tissue, the 
level and localization of their expression, by their interaction and their collaborative or 
conflicting signalling with others PRRs, can promote immunity or tolerance to commensal 
microorganisms. This idea could apply to other ITAM-coupled CLRs with a diverse ligand 
range or that can heterodimerize with multiple receptors (Ostrop and Lang, 2017) (Fig. 5.1 
and 5.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Proposed model for Mincle-mediated non-self recognition to immune evasion 
Upon binding of soluble low-avidity/affinity ligand from Leishmania major (1), there is an 
hypo-phosphorylation of the ITAM domain in the FcRγ chain (FcRγc) associated with Mincle, 
termed “inhibitory ITAM”, which preferentially binds the tyrosine phosphatase SHP-1 (2), 
dampening the activation of moDC (3) at the level of migration (4), costimulatory molecules (5) 
and cytokines production (5) suppressing the protective Th1 immune response (6). Mincle, 
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macrophage inducible C-type lectin; ITAM, immunoreceptor tyrosine-based activating motif; 
moDC, monocyte-derived dendritic cells; NO, nitric oxide; ROS, reactive oxygen species; 
(SHP)-1, src homology region 2 domain-containing phosphatase. The symbol P indicates motif 
phosphorylation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Proposed model for Mincle-mediated non-self recognition to promote 
commensalism. Upon recognition of Lactobacillus and/or other mucosa-associated commensals 
(1), the FcRγ chain ITAM is fully phosphorylated and associates with Syk kinase (2), which 
triggers an activating signal (IL-6 and IL-23 production) in PP DCs (3) contributing to mucosal 
barrier function at the level of Th17 and ILC activation (4), IgA production (5) and 
antimicrobial peptides secretion (6). IECs, intestinal epithelial cells;LysoDC, lysozyme-
expressing DCs; LysoMac, lysozyme-expressing macrophages; IFR, interfollicular regions, 
SED, subepithelial dome; Tfh, T follicular helper cells; ILC, innate lymphoid cell; Syk, spleen 
tyrosine kinase; RegIIIγ, regenerating islet-derived protein 3 gamma. The symbol P indicates 
motif phosphorylation. 
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6. CONCLUSIONS 
1. Leishmania releases a soluble ligand that binds human and mouse Mincle 
 
2. Mincle deficient mice show enhanced parasite-specific immune response with reduced 
parasite burden and pathology 
 
3. Leishmania inhibits activation and migration of DCs in a Mincle-dependent manner 
 
4. Leishmania shifts Mincle intracellular configuration in DCs, to an inhibitory FcRγ chain 
/SHP1 axis able to inhibit heterologous receptors-mediated signalling 
 
5. Mucosa-associated commensals contain ligands for human and mouse Mincle 
 
6. Mincle deficient and CD11cΔSyk mice have diminished intestinal IL-17 and IL-22 with  
reduced barrier function and increased commensal extravasation 
 
7. Mincle-commensals interaction triggers  IL-6 and IL-23p19 in Peyer’s patches 
 
8. Lysozyme-expressing DCs and CD11b+ DCs from PPs prime a microbiota- and Mincle-
Syk dependent Th17 immunity 
 
9. Intestinal Th17 cells and ILCs producing IL-17 and IL-22 require Mincle and Syk in 
CD11c+ cells 
 
10. Sensing commensals by Mincle promotes intestinal barrier function, including IgA and 
antimicrobial peptide production, thus limiting microbial translocation and liver 
inflammation 
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7. CONCLUSIONES 
1. Leishmania excreta un ligando soluble capaz de unirse a Mincle humano y de ratón 
 
2. Los ratones deficientes para Mincle tienen una mayor respuesta inmunitaria frente al 
parásito, acompañada de una menor carga parasitaria y menor patología 
 
3. Leishmania inhibe a través de Mincle la migración y activación de las DCs  
 
4.  Leishmania cambia la configuración intracelular de Mincle en las DCs hacia un eje 
inhibidor FcRγc /SHP1 capaz de parar la señalización mediada por receptores 
heterólogos  
 
5.  Los microorganismos comensales asociados a la mucosa intestinal contienen ligandos 
para Mincle humano y de ratón 
 
6. Los ratones deficientes para Mincle y CD11cΔSyk tienen menor cantidad de IL-17 e IL-
22, acompañado de una disfunción de la barrera intestinal y diseminación sistémica de 
los organismos comensales 
 
7. La interacción entre Mincle y los microorganismos comensales induce la producción de 
IL-6 e IL-23p19 en las PPs. 
 
8. Las DCs de las PPs que expresan lisozima y las DCs CD11b+ usan el eje de 
señalización Mincle/ FcRγ /Syk para promover la producción de IL-17 en respuesta a la 
microbiota 
 
9. La producción de IL-17 e IL-22 por parte de las células intestinales Th17 e ILCs, 
requiere la expresión de Mincle y Syk por parte de las células CD11c+ 
 
10.  El reconocimiento de los microorganismos comensales mediado por Mincle favorece la 
funcionalidad de la barrera intestinal, a nivel de IgA y de péptidos antimicrobianos, 
limitando la diseminación de los comensales y la inflamación hepática 
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